US20230018482A1 - End-capped polyisobutylene polyurethane - Google Patents
End-capped polyisobutylene polyurethane Download PDFInfo
- Publication number
- US20230018482A1 US20230018482A1 US17/951,682 US202217951682A US2023018482A1 US 20230018482 A1 US20230018482 A1 US 20230018482A1 US 202217951682 A US202217951682 A US 202217951682A US 2023018482 A1 US2023018482 A1 US 2023018482A1
- Authority
- US
- United States
- Prior art keywords
- residue
- diisocyanate
- polymeric material
- polyisobutylene
- copolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002367 Polyisobutene Polymers 0.000 title claims abstract description 46
- 239000004814 polyurethane Substances 0.000 title claims abstract description 33
- 229920002635 polyurethane Polymers 0.000 title claims abstract description 32
- 150000002009 diols Chemical group 0.000 claims abstract description 81
- 150000001412 amines Chemical class 0.000 claims abstract description 62
- 125000005442 diisocyanate group Chemical group 0.000 claims abstract description 59
- 239000000463 material Substances 0.000 claims abstract description 53
- 229920001400 block copolymer Polymers 0.000 claims abstract description 20
- 239000004202 carbamide Substances 0.000 claims abstract description 7
- 239000004970 Chain extender Substances 0.000 claims description 33
- 229920001577 copolymer Polymers 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 27
- -1 polytetramethylene Polymers 0.000 claims description 23
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical group C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 16
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 16
- 229920000570 polyether Polymers 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 14
- 125000001931 aliphatic group Chemical group 0.000 claims description 13
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical group OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 150000003141 primary amines Chemical class 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000004417 polycarbonate Substances 0.000 claims description 7
- 229920000515 polycarbonate Polymers 0.000 claims description 7
- 229920000728 polyester Polymers 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000012970 tertiary amine catalyst Substances 0.000 claims description 3
- 239000011874 heated mixture Substances 0.000 claims description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical group CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 70
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 48
- 238000007792 addition Methods 0.000 description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- AVWRKZWQTYIKIY-UHFFFAOYSA-N urea-1-carboxylic acid Chemical compound NC(=O)NC(O)=O AVWRKZWQTYIKIY-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000010382 chemical cross-linking Methods 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 150000003335 secondary amines Chemical class 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- WWRUOBBEFDYYJF-UHFFFAOYSA-N 1-tert-butyl-3,5-bis(2-methoxypropan-2-yl)benzene Chemical compound COC(C)(C)C1=CC(C(C)(C)C)=CC(C(C)(C)OC)=C1 WWRUOBBEFDYYJF-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 3
- 238000010907 mechanical stirring Methods 0.000 description 3
- 238000000569 multi-angle light scattering Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 description 2
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 238000007787 electrohydrodynamic spraying Methods 0.000 description 2
- 238000001523 electrospinning Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 229920003224 poly(trimethylene oxide) Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- ATOUXIOKEJWULN-UHFFFAOYSA-N 1,6-diisocyanato-2,2,4-trimethylhexane Chemical compound O=C=NCCC(C)CC(C)(C)CN=C=O ATOUXIOKEJWULN-UHFFFAOYSA-N 0.000 description 1
- 229940008841 1,6-hexamethylene diisocyanate Drugs 0.000 description 1
- MNKFLCYZIHOFRQ-UHFFFAOYSA-N 1-cyclohexyl-n,n-dimethylmethanamine Chemical compound CN(C)CC1CCCCC1 MNKFLCYZIHOFRQ-UHFFFAOYSA-N 0.000 description 1
- LFSYUSUFCBOHGU-UHFFFAOYSA-N 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=CC=C1N=C=O LFSYUSUFCBOHGU-UHFFFAOYSA-N 0.000 description 1
- DTZHXCBUWSTOPO-UHFFFAOYSA-N 1-isocyanato-4-[(4-isocyanato-3-methylphenyl)methyl]-2-methylbenzene Chemical compound C1=C(N=C=O)C(C)=CC(CC=2C=C(C)C(N=C=O)=CC=2)=C1 DTZHXCBUWSTOPO-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- PZHXTCOVSRHUSS-UHFFFAOYSA-N 2-(2-phenylpropan-2-yloxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OC(C)(C)C1=CC=CC=C1 PZHXTCOVSRHUSS-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- BOZRCGLDOHDZBP-UHFFFAOYSA-N 2-ethylhexanoic acid;tin Chemical compound [Sn].CCCCC(CC)C(O)=O BOZRCGLDOHDZBP-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- MRFQFQYRTNGOCZ-UHFFFAOYSA-N 2-methoxypropan-2-ylbenzene Chemical compound COC(C)(C)C1=CC=CC=C1 MRFQFQYRTNGOCZ-UHFFFAOYSA-N 0.000 description 1
- WJIOHMVWGVGWJW-UHFFFAOYSA-N 3-methyl-n-[4-[(3-methylpyrazole-1-carbonyl)amino]butyl]pyrazole-1-carboxamide Chemical compound N1=C(C)C=CN1C(=O)NCCCCNC(=O)N1N=C(C)C=C1 WJIOHMVWGVGWJW-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004903 cardiac system Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- CAPAZTWTGPAFQE-UHFFFAOYSA-N ethane-1,2-diol Chemical compound OCCO.OCCO CAPAZTWTGPAFQE-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Polymers 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- UKODFQOELJFMII-UHFFFAOYSA-N pentamethyldiethylenetriamine Chemical compound CN(C)CCN(C)CCN(C)C UKODFQOELJFMII-UHFFFAOYSA-N 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/62—Polymers of compounds having carbon-to-carbon double bonds
- C08G18/6204—Polymers of olefins
- C08G18/6208—Hydrogenated polymers of conjugated dienes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/143—Stabilizers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
- C08G18/12—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/2805—Compounds having only one group containing active hydrogen
- C08G18/285—Nitrogen containing compounds
- C08G18/2865—Compounds having only one primary or secondary amino group; Ammonia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/4009—Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
- C08G18/4063—Mixtures of compounds of group C08G18/62 with other macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4804—Two or more polyethers of different physical or chemical nature
- C08G18/4808—Mixtures of two or more polyetherdiols
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/4854—Polyethers containing oxyalkylene groups having four carbon atoms in the alkylene group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/62—Polymers of compounds having carbon-to-carbon double bonds
- C08G18/6204—Polymers of olefins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
- C08G18/7657—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
- C08G18/7664—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups
- C08G18/7671—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups containing only one alkylene bisphenyl group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/83—Chemically modified polymers
- C08G18/833—Chemically modified polymers by nitrogen containing compounds
Definitions
- the present disclosure relates to polymeric materials. More specifically, the disclosure relates to polyisobutylene-polyurethane block copolymers, methods for making polyisobutylene-polyurethane block copolymers, and medical devices containing polyisobutylene-polyurethane block copolymers
- Polymeric materials are widely used in the field of medical devices.
- polymeric materials such as silicone rubber, polyurethane, and fluoropolymers are used as coating and/or insulating materials for medical leads, stents, catheters, and other devices.
- Block copolymers are polymeric materials made of alternating sections of polymerized monomers.
- Polyisobutylene-polyurethane block copolymers are polymeric materials with many unique physical and mechanical properties. Exemplary properties, which may be particularly desirable in the field of medical devices, include thermal stability, chemical resistance, biocompatibility, and gas impermeability, among others.
- incorporación of polymeric materials into implantable medical devices may be done by a variety of methods, depending on the specific application.
- the polymeric material may be extruded at a temperature sufficient to cause the block copolymer to flow, but not high enough to cause the polymeric material to break down. That is, the material that forms the lead after the extrusion and cooling has largely the same structure as the original polymeric material.
- solvent-based processing includes electrospraying, electrospinning, spray coating, dip coating, and force spinning. Essential to all solvent-based processing of polymeric materials is the ability to bring the polymeric material into solution while retaining the basic structure of the polymeric material.
- Example 1 is a polymeric material including a polyisobutylene-polyurethane block copolymer.
- the polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups.
- the soft segments include a polyisobutylene diol residue.
- the hard segments include a diisocyanate residue.
- the end groups are bonded by urea bonds to a portion of the diisocyanate residue.
- the end groups include a residue of a mono-functional amine.
- Example 2 is the polymeric material of Example 1, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 3 is the polymeric material of either of Examples 1 or 2, wherein the mono-functional amine includes a C 3 to C 30 aliphatic chain.
- Example 4 is the polymeric material of any of Examples 1-3, wherein the mono-functional amine is butylamine.
- Example 5 is the polymeric material of any of Examples 1-4, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 6 is the polymeric material of any of Examples 1-5, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 7 is the polymeric material of any of Examples 1-6, wherein the hard segments further include a chain extender residue.
- Example 8 is the polymeric material of Example 7, wherein the chain extender residue is 1,4-butanediol residue.
- Example 9 is the polymeric material of any of Examples 1-8, wherein the soft segments further include at least one of a polyether diol residue, a polyester diol residue, and a polycarbonate diol residue.
- Example 10 is a medical device including the polymeric material of any of Examples 1-9.
- Example 11 is a method of making a polymeric material.
- the method includes heating a mixture of soft segment components and hard segment components to an elevated temperature to form a prepolymer, reacting a chain extender with the prepolymer to form a polymer, and reacting an end capping agent with at least one of: the prepolymer and the polymer to form the polymeric material.
- the soft segment components include a polyisobutylene diol.
- the hard segment components include a diisocyanate.
- the end capping agent includes a mono-functional amine.
- Example 12 is the method of Example 11, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 13 is the method of either of Examples 11 or 12, wherein the mono-functional amine includes a C 3 to C 30 aliphatic chain.
- Example 14 is the method of any of Examples 11-13, wherein the mono-functional amine is butylamine.
- Example 15 is the method of any of Examples 11-14, wherein the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol and the chain extender, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- Example 16 is a polymeric material including a polyisobutylene-polyurethane block copolymer.
- the polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups.
- the soft segments include a polyisobutylene diol residue.
- the hard segments include a diisocyanate residue.
- the end groups are bonded by urea bonds to a portion of the diisocyanate residue.
- the end groups include a residue of a mono-functional amine including a C 3 to C 30 aliphatic chain.
- Example 17 is the polymeric material of Example 16, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 18 is the polymeric material of Example of either of Examples 16 or 17, wherein the mono-functional amine is butylamine.
- Example 19 is the polymeric material of any of Examples 16-18, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 20 is the polymeric material of any of Examples 16-19, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 21 is the polymeric material of any of Examples 16-19, wherein the hard segments further include a chain extender residue.
- Example 22 is the polymeric material of Example 21, wherein the chain extender residue is 1,4-butanediol residue.
- Example 23 is the polymeric material of any of Examples 16-22, wherein the soft segments further include at least one of: a polyether diol residue, a polyester diol residue, and a polycarbonate dial residue.
- Example 24 a medical device including a polymeric material.
- the polymeric material includes a polyisobutylene-polyurethane block copolymer.
- the polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups.
- the soft segments include a polyisobutylene diol residue.
- the hard segments include a diisocyanate residue.
- the end groups are bonded by urea bonds to a portion of the diisocyanate residue.
- the end groups include a residue of a mono-functional amine including a C 3 to C 30 aliphatic chain.
- Example 25 is the medical device of Example 24, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 26 is the medical device of either of Examples 24 or 25, wherein the mono-functional amine is butylamine.
- Example 27 is the medical device of any of Examples 24-26, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 28 is the medical device of any of Examples 24-27, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 29 is a method of making a polymeric material.
- the method includes heating a mixture of soft segment components and hard segment components to an elevated temperature to form a prepolymer, reacting a chain extender with the prepolymer to form a polymer, and reacting an end capping agent with at least one of: the prepolymer and the polymer to form the polymeric material.
- the soft segment components include a polyisobutylene diol.
- the hard segment components include a diisocyanate.
- the end capping agent includes a mono-functional amine including a C 3 to C 30 aliphatic chain.
- Example 30 is the method of Example 29, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 31 is the method of either of Examples 29 or 30, wherein the mono-functional amine is butylamine.
- Example 32 is the method of any of Examples 29-31, wherein the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol and the chain extender, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- Example 33 is the method of any of Examples 29-32, wherein heating the mixture of the soft segment components and the hard segment components to an elevated temperature and reacting the chain extender with the heated mixture are in the presence of a tertiary amine catalyst.
- Example 34 is the method of Example 29, wherein the diisocyanate includes 4,4′-methylene diphenyl diisocyanate.
- Example 35 is the method of any of Examples 29-34, wherein the soft segment components further include a polytetramethylene oxide diol, the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol, the chain extender, and the polytetramethylene oxide diol, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- the soft segment components further include a polytetramethylene oxide diol
- the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol
- the chain extender and the polytetramethylene oxide diol
- the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- FIG. 1 is a schematic diagram illustrating a first step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure.
- FIG. 2 is a schematic diagram illustrating a second step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure.
- FIG. 3 is a schematic diagram illustrating another process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure.
- FIG. 4 is a plot of dynamic viscosity as a function of concentration for polyisobutylene-polyurethane solutions according to some embodiments of this disclosure.
- polyisobutylene-polyurethane block copolymers also referred to herein collectively as “PIB-PUR”
- PIB-PUR is a thermoplastic polyurethane (TPUs) that contains hard and soft segments.
- TPUs thermoplastic polyurethane
- PIB-PUR is useful in a number of applications, including in medical devices used for insertion or implantation into a patient because they are hydrolytically stable and have good oxidative stability.
- Polyurethanes are a family of copolymers that are synthesized from polyfunctional isocyanates (e.g., diisocyanates, including both aliphatic and aromatic diisocyanates) and polyols (e.g., macroglycols).
- polyfunctional isocyanates e.g., diisocyanates, including both aliphatic and aromatic diisocyanates
- polyols e.g., macroglycols
- Commonly employed macroglycols include polyester diols, polyether diols and polycarbonate diols.
- the macroglycols can form polymeric segments of the polyurethane.
- Aliphatic or aromatic diols may also be employed as chain extenders, for example, to impart improved physical properties to the polyurethane.
- the polyisobutylene urethane copolymer includes one or more polyisobutylene segments, one or more segments that includes one or more diisocyanate residues, optionally one or more additional polymeric segments (other than polyisobutylene segments), and optionally one or more chain extenders.
- a “polymeric segment” or “segment” is a portion of a polymer.
- the polyisobutylene segments of the polyisobutylene urethane copolymers are generally considered to constitute soft segments, while the segments containing the diisocyanate residues are generally considered to constitute hard segments.
- the additional polymeric segments may include soft or hard polymeric segments.
- soft and hard segments are relative terms to describe the properties of polymer materials containing such segments. Without limiting the foregoing, a soft segment may display a glass transition temperature (Tg) that is below body temperature, more typically from 35° C. to 20° C. to 0° C. to ⁇ 25° C. to ⁇ 50° C. or below.
- Tg glass transition temperature
- a hard segment may display a Tg that is above body temperature, more typically from 40° C. to 50° C. to 75° C. to 100° C. or above.
- Tg can be measured by differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA) and/or thermomechanical analysis (TMA).
- DSC differential scanning calorimetry
- DMA dynamic mechanical analysis
- TMA thermomechanical analysis
- the weight ratio of soft segments to hard segments in the polyisobutylene urethane copolymers of the various embodiments can be varied to achieve a wide range of physical and mechanical properties, and to achieve an array of desirable functional performance.
- the weight ratio of soft segments to hard segments in the polymer can be varied from 99:1 to 95:5 to 90:10 to 75:25 to 50:50 to 25:75 to 10:90 to 5:95 to 1:99, more particularly from 95:5 to 90:10 to 80:20 to 70:30 to 65:35 to 60:40 to 50:50, and even more particularly, from about 80:20 to about 50:50.
- the soft segment components can be about 40% to about 70% by weight of the copolymer, and the hard segment components can be about 30% to about 60% by weight of the copolymer.
- the copolymer may include polyisobutylene in an amount of about 60% to about 100% by weight of the soft segments and a polyether, a polyester, or a polycarbonate in an amount of about 0% to about 40% by weight of the soft segments.
- the copolymer may include soft segments in an amount of about 40% to about 70% by weight of the copolymer, of which polyisobutylene is present in an amount of about 60% to about 100% by weight of the soft segments and polyether is present in an amount of about 0% to about 40% by weight of the soft segments.
- the copolymer may include soft segments in an amount of about 40% to about 70% by weight of the copolymer, of which polyisobutylene (e.g., a polyisobutylene diol residue) is present in an amount of about 70% to about 95% by weight of the soft segments and a polyether (e.g., polytetramethylene oxide diol residue) is present in an amount of about 5% to about 40% by weight of the soft segments.
- polyisobutylene e.g., a polyisobutylene diol residue
- a polyether e.g., polytetramethylene oxide diol residue
- Diisocyanates for use in forming PIB-PUR of the various embodiments include aromatic and non-aromatic (e.g., aliphatic) diisocyanates.
- Aromatic diisocyanates may be selected from suitable members of the following, among others: 4,4′-methylenediphenyl diisocyanate (MDI), 2,4′-methylenediphenyl diisocyanate (2,4-MDI), 2,4- and/or 2,6-toluene diisocyanate (TDI), 1,5-naphthalene diisocyanate (NDI), para-phenylene diisocyanate, 3,3′-tolidene-4,4′-diisocyanate and 3,3′-dimethyl-diphenylmethane-4,4′-diisocyanate.
- MDI 4,4′-methylenediphenyl diisocyanate
- TDI 2,
- Non-aromatic diisocyanates may be selected from suitable members of the following, among others: 1,6-hexamethylene diisocyanate (HDI), 4,4′-dicyclohexylmethane diisocyanate (H12-MDI), 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate (isophorone diisocyanate or IPDI), cyclohexyl diisocyanate, and 2,2,4-trimethyl-1,6-hexamethylene diisocyanate (TMDI).
- HDI 1,6-hexamethylene diisocyanate
- H12-MDI 4,4′-dicyclohexylmethane diisocyanate
- IPDI isophorone diisocyanate
- cyclohexyl diisocyanate 2,2,4-trimethyl-1,6-hexamethylene diisocyanate
- a polyether diol such as polytetramethylene oxide diol (PTMO diol), polyhexametheylene oxide diol (PHMO diol), polyoctamethylene oxide diol or polydecamethylene oxide diol, can be combined with a polyisobutylene diol and diisocyanate to form a polyisobutylene polyurethane copolymer.
- PIB-PUR may have a generally uniform distribution of polyurethane hard segments, polyisobutylene segments and polyether segments to achieve favorable micro-phase separation in the polymer.
- polyether segments may improve key mechanical properties such as Shore hardness, tensile strength, tensile modulus, flexural modulus, elongation tear strength, flex fatigue, tensile creep, and/or abrasion performance, among others.
- the polyisobutylene diol may be a telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with a difunctional initiator compound, such as 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene (hindered dicumyl ether).
- a difunctional initiator compound such as 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene (hindered dicumyl ether).
- PIB-PUR in accordance with the various embodiments may further include one or more optional chain extender residues.
- Chain extenders can increase the hard segment length, which can in turn results in a copolymer with a higher tensile modulus, lower elongation at break and/or increased strength.
- Chain extenders can be formed from aliphatic or aromatic diols, in which case a urethane bond is formed upon reaction with an isocyanate group.
- Chain extenders may be selected from suitable members of the following, among others: 1,4 cyclohexanedimethanol, alpha,omega-alkane diols such as ethylene glycol (1,2-ethane diol), 1,4-butanediol (BDO), and 1,6-hexanediol.
- Chain extenders may be also selected from suitable members of, among others, short chain diol polymers (e.g., alpha,omega-dihydroxy-terminated polymers having a molecular weight less than or equal to 1000) based on hard and soft polymeric segments (more typically soft polymeric segments) such as those described above, including short chain polyisobutylene diols, short chain polyether polyols such as polytetramethylene oxide diols, short chain polysiloxane diols such as polydimethylsiloxane dials, short chain polycarbonate diols such as polyhexamethylene carbonate diols, short chain poly(fluorinated ether) diols, short chain polyester dials, short chain polyacrylate dials, short chain polymethacrylate dials, and short chain polyvinyl aromatic) dials. Chain extenders may also be selected form suitable glycols, such as propylene glycol, dipropylene glycol, and tripropylene glycol.
- the PIB-PUR may be synthesized and stored for a period of time until it is incorporated into the solvent processing.
- the FIB-PUR may be stored for a period of days, weeks or months.
- the PIB-PUR is dissolved in a solvent, such as, for example, 2,6-dimethylpyridine or tetrahydrofuran (THF), to obtain a desired concentration and/or viscosity of the resulting PIB-PUR solution.
- the PIB-PUR solution can then be deposited onto a substrate, such as a medical device, by electrospraying, electrospinning, spray coating, dip coating, or force spinning.
- the molecular weight (both the weight average molecular weight (Mw) and the number average molecular weight (Mn)) of the PIB-PUR can increase during the storage period.
- the stored PIB-PUR forms a gel.
- Such gels are that is no longer easily soluble in 2,6-dimethylpyridine or THF and thus, no longer suitable for solvent-based processing.
- an end-capping agent that is a mono-functional amine can mitigate the increase in molecular weight due to extended storage time.
- the addition of such an end capping agent to PIB-PUR that has been stored for an extended period of time can reverse the increase in molecular weight of the PIB-PUR.
- the addition of such an end capping agent to PIB-PUR even after is has gelled and is no longer soluble in 2,6-dimethylpyridine or THF can break down the cross-links in the gel so that the PIB-PUR is soluble in 2,6-dimethylpyridine or THF.
- a gel is defined as a substantially dilute cross-linked system which exhibits no flow when in a steady-state.
- the mono-functional amine can include a C 3 to C 30 aliphatic chain that can be straight or branched, saturated or unsaturated, a primary amine or a secondary amine.
- the mono-functional amine can be a butylamine or a butylamine ether, such as 2-methoxy ethylamine.
- FIG. 1 is a schematic diagram illustrating a first step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure.
- a polymeric material including PIB-PUR according to embodiments of this disclosure can be made by mixing soft segment components 10 , including polyisobutylene diol 12 and optional polyether diol 14 (PTMO is illustrated), and hard segment component 16 , including a diisocyanate 18 (MDI is illustrated), together and heating the mixture to an elevated temperature in the presence of a catalyst 20 to form a prepolymer 22 .
- soft segment components 10 including polyisobutylene diol 12 and optional polyether diol 14 (PTMO is illustrated)
- PTMO polyether diol 14
- MDI diisocyanate 18
- An elevated temperature is any temperature above room temperature, such as 30° C., 40° C., 50° C., 60° C., 70° C., 80° C., 90° C., or 100° C., or any temperature between any of the preceding temperatures.
- the catalyst can be any suitable catalyst, such as, an organometallic catalyst, for example, tin(II) 2-ethylhexanoate (stannous octoate), or a tertiary amine catalyst, for example, 2,6-dimethylpyridine, 1-cyclohexyl-N,N-dimethylmethanamine, N,N,N′,N′,N′′-pentamethyldiethylenetriamine, or 4-methylmorpholine, 1-methylimidazole.
- organometallic catalyst for example, tin(II) 2-ethylhexanoate (stannous octoate)
- a tertiary amine catalyst for example, 2,6-dimethylpyridine, 1-
- the second step is shown in FIG. 2 .
- a chain extender 24 (BDO is illustrated) is reacted at an elevated temperature with the prepolymer 22 , along with the mono-functional amine 26 (butylamine is illustrated) in the presence of the catalyst 20 to form a PIB-PUR 28 .
- the mono-functional amine 26 caps the ends of the PIB-PUR 28 , reacting with the diisocyanate 18 to prevent further chain extension.
- the mono-functional amine 26 may also react with excess diisocyanate 18 and reduce unwanted side reactions.
- the mono-functional amine 26 may be added to the prepolymer 22 at the same time as the chain extender 24 .
- the mono-functional amine 26 may be added after the chain extender 24 has at least partially reacted with the prepolymer 22 to form a polymer. In some embodiments, the mono-functional amine 26 may be added to the prepolymer 22 at the same time as the chain extender 24 and after the chain extender 24 has at least partially reacted with the prepolymer 22 to form a polymer.
- the diisocyanate 18 can be in stoichiometric excess with respect to the polyisobutylene diol 12 , the optional polyether diol 14 , and the chain extender 24 .
- the diisocyanate 18 may be in excess to account for diisocyanate lost to reactions with residual water.
- the diisocyanate 18 is in excess with respect to the polyisobutylene diol 12 , the optional polyether 14 , and the chain extender 24 by as little as 0.5 mole percent (mol %), 1 mol % 1.5 mol %, or 2 mol %, or as much as 2.5 mol %, 3 mol %, 4 mol %, or 5 mol %, or any value between any two of the preceding values.
- the diisocyanate 18 is in excess with respect to the polyisobutylene diol 12 , the optional polyether 14 , and the chain extender 24 by from 0.5 mol % to 5 mol %, 1 mol % to 4 mol %, 1.5 mol % to 3 mol %, 2 mol % to 2.5 mol %, or 0.5 mol % to 2.5 mol %.
- the mono-functional amine 26 can be added in at least equimolar amounts with respect to the diisocyanate 18 . In some embodiments, an excess of the mono-functional amine 26 can be added. If necessary, some of the excess mono-functional amine 26 can be removed by heating above the boiling point of the mono-functional amine 26 . For example, excess butylamine can be removed by heating above about 78° C., the boiling point of butylamine.
- the PIB-PUR 28 illustrated in FIG. 2 is a polymeric material including at least soft segments including a residue of the polyisobutylene diol 12 , hard segments including at least residue of the diisocyanate 18 , and end groups bonded to some of the diisocyanate residue by a urea bond.
- the end groups are a residue of the mono-functional amine 26 .
- the hard segments of the embodiment shown in FIG. 2 further include a residue of the chain extender 24 .
- the soft segments of the embodiment shown in FIG. 2 also further include a residue of the polyether diol 14 .
- the soft segments can alternatively or additionally include a residue of a polycarbonate diol and/or a polyester diol.
- FIG. 3 is a schematic diagram illustrating another process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure.
- the mono-functional amine 26 (butylamine is shown) is added after the polymerization reaction is at least substantially complete.
- the polymerization reaction is at least substantially complete when there is no noticeable increase in the viscosity of the polyisobutylene-polyurethane over a period of several hours.
- FIG. 3 shows a PIB-PUR chain 30 and a diisocyanate residue 32 bonded to a urethane linkage of the PIB-PUR 30 to form an allophanate 34 .
- the PIB-PUR 30 may have been produced and end-capped with a mono-functional amine as for PIB-PUR 28 described above. In other embodiments, the PIB-PUR 30 may not have been end-capped with a mono-functional amine when initially synthesized.
- the diisocyanate residue 32 may be a result of the excess of diisocyanate used to make the PIB-PUR 30 as described above.
- the diisocyanate residue 32 also bonds with other hard or soft segment components, including other chains of the PIB-PUR 30 (not shown), thus cross-linking the other hard or soft segment components to the PIB-PUR 30 , increasing the molecular weight of the PIB-PUR 30 , and eventually gelling the PIB-PUR 30 as described above.
- These side reactions can form the allophanate 34 .
- Other side reactions can form other cross-linking structures, such as a biuret (not shown).
- the allophanate 34 is a reversible bond. As noted above, it has been found that the addition of the mono-functional amine 26 , even after the PIB-PUR 30 has gelled, reverses the gelling of the PIB-PUR 30 and reduces its molecular weight. Without wishing to be bound by any theory, it is believed that the steric hindrance associated with the allophanate 34 weakens the bond, resulting in the reversible bond shown in FIG. 3 . It is believed that the diisocyanate residue 32 bonds preferentially with the mono-functional amine 26 , tying up the diisocyanate residue 32 in a more stable alkyl amine 36 (a butyl amine shown), as shown in FIG. 3 .
- Tying up the diisocyanate reside 32 may prevent reformation of the allophanate 34 and reduce the cross-linking of the other hard or soft segment components to the PIB-PUR 30 , breaking down the gelation of the PIB-PUR 30 and reducing the molecular weight of the PIB-PUR 30 .
- the molecular weight of the PIB-PUR 30 may be reduced to an initial molecular weight of a linear chain of PIB-PUR 30 .
- the amine termination of the mono-functional amine 26 is believed to be well suited to this application, in contrast to, for example, a similarly-structured mono-functional alcohol. It has been found that while the mono-functional amine 26 is effective in reversing gelation of the PIB-PUR 30 , a similarly-structured mono-functional alcohol is not effective.
- the PIB-PUR 26 or PIB-PUR 30 can be incorporated into medical devices which can be implanted or inserted into the body of a patient.
- Example medical devices may include, without limitation, vascular grafts, electrical leads, catheters, leadless cardiac pacemakers (LCP), pelvic floor repair support devices, shock coil coverings, covered stents, urethral stents, internal feeding tubes/balloons, structural heart applications including valve leaflets, suture sleeves, breast implants, ophthalmic applications including intraocular lenses and glaucoma tubes, and spinal disc repair.
- Example electrical leads may include, without limitation, implantable electrical stimulation or diagnostic systems including neurostimulation systems such as spinal cord stimulation (SCS) systems, deep brain stimulation (DBS) systems, peripheral nerve stimulation (PNS) systems, gastric nerve stimulation systems, cochlear implant systems, and retinal implant systems, among others, and cardiac systems including implantable cardiac rhythm management (CRM) systems, implantable cardioverter-defibrillators (ICD's), and cardiac resynchronization and defibrillation (CRDT) devices, among others.
- neurostimulation systems such as spinal cord stimulation (SCS) systems, deep brain stimulation (DBS) systems, peripheral nerve stimulation (PNS) systems, gastric nerve stimulation systems, cochlear implant systems, and retinal implant systems, among others
- cardiac systems including implantable cardiac rhythm management (CRM) systems, implantable cardioverter-defibrillators (ICD's), and cardiac resynchronization and defibrillation (CRDT) devices, among others.
- CCM implantable cardiac rhythm management
- Polyisobutylene-polyurethane block copolymer including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle, 106 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-feat-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 72 grams of 4′-methylenediphenyl diisocyanate (MDI), and 56 grams of polytetramethylene oxide diol were dissolved in 545 grams of 2,6-dimethylpyridine.
- MDI 4′-methylenediphenyl diisocyanate
- the 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas.
- the polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole.
- the solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 16 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- the PIB-PUR was stored at room temperature in a sealed container. After 15 days, the PIB-PUR was characterized by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The PIB-PUR was recharacterized after 63 days and 98 days. The results are shown in Table 1 below. As shown in Table 1 the molecular weight increased, particularly between 64 and 98 days. At 98 days, the PIB-PUR was observed to have gelled. The gelled FIB-FUR was found to be predominantly insoluble in either 2,6-dimethylpyridine or THF, indicating that chemical cross-linking of the PIB-PUR had occurred (the molecular weight was determined from a soluble fraction).
- GPC-MALLS multi angle light scattering detector
- the gelled PIB-PUR was treated with butylamine in excess equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.5 g of butylamine to 1 g of the gelled PIB-PUR, and then shaking on a shaker table at 225 rpm at 30° C. for about 12 hours.
- the treated PIB-PUR became a viscous liquid again indicating that whatever chemical cross-linking had taken place appeared to have been reversed with the addition of the butylamine.
- the treated PIB-PUR solution was recharacterized after 24 hours and after 25 days. The results are also shown in Table 1. As shown in Table 1, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine.
- Polyisobutylene-polyurethane block copolymer including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle, 105 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 72 grams of 4′-methylenediphenyl diisocyanate (MDI), and 57 grams of polytetramethylene oxide diol were dissolved in 546 grams of 2,6-dimethylpyridine.
- telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene
- MDI 4′-methylenediphenyl diisocyanate
- the 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas.
- the polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole.
- the solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 16 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- the PIB-PUR was stored at room temperature in a sealed container.
- the PIB-PUR was characterized after 24 days by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The results are shown in Table 2 below.
- GPC-MALLS multi angle light scattering detector
- the PIB-PUR was treated with butylamine in at least equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.08 g of butylamine to 1 g of the PIB-PUR, and then shaken on a shaker table at 225 rpm at 30° C. for about 12 hours.
- the treated PIB-PUR solution was stored at room temperature in a sealed container and recharacterized after 24 hours.
- Table 2 As shown in Table 2, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine.
- a dynamic viscosity was measured for various concentrations of the PIB-PUR of Example 2 in 2,6-dimethylpyridine before treatment 40 and 24 hours after treatment 42 with the butylamine.
- Three PIB-PUR solutions of various concentrations were prepared for each of the before treatment 40 and after treatment 42 by adding appropriate amounts of 2,6-dimethylpyridine. The results are shown in FIG. 4 .
- the dynamic viscosity dropped significantly with the addition of the butylamine, again suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine.
- Polyisobutylene-polyurethane block copolymer including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle 13 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 9 grams of 4′-methylenediphenyl diisocyanate (MDI), and 7 grams of polytetramethylene oxide diol were dissolved in 8 grams of 2,6-dimethylpyridine.
- MDI 4′-methylenediphenyl diisocyanate
- the 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas.
- the polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole.
- the solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 2 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- the PIB-PUR was stored at room temperature in a sealed container.
- the PIB-PUR was characterized after 21 days by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The results are shown in Table 3 below.
- the PIB-PUR was treated with butylamine in at least equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.08 g of butylamine to 1 g of the PIB-PUR, and then shaken on a shaker table at 225 rpm at 30° C. for about 12 hours.
- the treated PIB-PUR solution was stored at room temperature in a sealed container and recharacterized after 24 hours and after 17 days.
- Table 3 As shown in Table 3, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine suggesting that at least some of the chemical cross-linking that had taken place over 21 days appeared to have been reversed with the addition of the butylamine. As further shown in Table 3, the cross-links did not reappear over an additional 17 days of storage.
- a dynamic viscosity was measured for various concentrations of the FIB-FUR of Example 2 in 2,6-dimethylpyridine before treatment 44 and 24 hours after treatment 46 with the butylamine.
- Three PIB-PUR solutions of various concentrations were prepared for each of the before treatment 40 and after treatment 42 by adding appropriate amounts of 2,6-dimethylpyridine. The results are shown in FIG. 4 .
- the dynamic viscosity dropped significantly with the addition of the butylamine, again suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine.
Abstract
Description
- The present application is a continuation of and claims priority to U.S. patent application Ser. No. 16/248,498, filed Jan. 15, 2019 and claims priority to U.S. Provisional Application No. 62/618,262, filed Jan. 17, 2018, both of which are herein incorporated by reference in their entirety.
- The present disclosure relates to polymeric materials. More specifically, the disclosure relates to polyisobutylene-polyurethane block copolymers, methods for making polyisobutylene-polyurethane block copolymers, and medical devices containing polyisobutylene-polyurethane block copolymers
- Polymeric materials are widely used in the field of medical devices. For example, polymeric materials such as silicone rubber, polyurethane, and fluoropolymers are used as coating and/or insulating materials for medical leads, stents, catheters, and other devices.
- Block copolymers are polymeric materials made of alternating sections of polymerized monomers. Polyisobutylene-polyurethane block copolymers are polymeric materials with many unique physical and mechanical properties. Exemplary properties, which may be particularly desirable in the field of medical devices, include thermal stability, chemical resistance, biocompatibility, and gas impermeability, among others.
- Incorporating polymeric materials into implantable medical devices may be done by a variety of methods, depending on the specific application. In some applications, for example, for implantable lead bodies, the polymeric material may be extruded at a temperature sufficient to cause the block copolymer to flow, but not high enough to cause the polymeric material to break down. That is, the material that forms the lead after the extrusion and cooling has largely the same structure as the original polymeric material.
- In other applications, it may be desirable to employ solvent-based processing to incorporate a polymeric material into an implantable medical device. Solvent-based processing includes electrospraying, electrospinning, spray coating, dip coating, and force spinning. Essential to all solvent-based processing of polymeric materials is the ability to bring the polymeric material into solution while retaining the basic structure of the polymeric material.
- Example 1 is a polymeric material including a polyisobutylene-polyurethane block copolymer. The polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups. The soft segments include a polyisobutylene diol residue. The hard segments include a diisocyanate residue. The end groups are bonded by urea bonds to a portion of the diisocyanate residue. The end groups include a residue of a mono-functional amine.
- Example 2 is the polymeric material of Example 1, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 3 is the polymeric material of either of Examples 1 or 2, wherein the mono-functional amine includes a C3 to C30 aliphatic chain.
- Example 4 is the polymeric material of any of Examples 1-3, wherein the mono-functional amine is butylamine.
- Example 5 is the polymeric material of any of Examples 1-4, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 6 is the polymeric material of any of Examples 1-5, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 7 is the polymeric material of any of Examples 1-6, wherein the hard segments further include a chain extender residue.
- Example 8 is the polymeric material of Example 7, wherein the chain extender residue is 1,4-butanediol residue.
- Example 9 is the polymeric material of any of Examples 1-8, wherein the soft segments further include at least one of a polyether diol residue, a polyester diol residue, and a polycarbonate diol residue.
- Example 10 is a medical device including the polymeric material of any of Examples 1-9.
- Example 11 is a method of making a polymeric material. The method includes heating a mixture of soft segment components and hard segment components to an elevated temperature to form a prepolymer, reacting a chain extender with the prepolymer to form a polymer, and reacting an end capping agent with at least one of: the prepolymer and the polymer to form the polymeric material. The soft segment components include a polyisobutylene diol. The hard segment components include a diisocyanate. The end capping agent includes a mono-functional amine.
- Example 12 is the method of Example 11, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 13 is the method of either of Examples 11 or 12, wherein the mono-functional amine includes a C3 to C30 aliphatic chain.
- Example 14 is the method of any of Examples 11-13, wherein the mono-functional amine is butylamine.
- Example 15 is the method of any of Examples 11-14, wherein the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol and the chain extender, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- Example 16 is a polymeric material including a polyisobutylene-polyurethane block copolymer. The polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups. The soft segments include a polyisobutylene diol residue. The hard segments include a diisocyanate residue. The end groups are bonded by urea bonds to a portion of the diisocyanate residue. The end groups include a residue of a mono-functional amine including a C3 to C30 aliphatic chain.
- Example 17 is the polymeric material of Example 16, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 18 is the polymeric material of Example of either of Examples 16 or 17, wherein the mono-functional amine is butylamine.
- Example 19 is the polymeric material of any of Examples 16-18, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 20 is the polymeric material of any of Examples 16-19, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 21 is the polymeric material of any of Examples 16-19, wherein the hard segments further include a chain extender residue.
- Example 22 is the polymeric material of Example 21, wherein the chain extender residue is 1,4-butanediol residue.
- Example 23 is the polymeric material of any of Examples 16-22, wherein the soft segments further include at least one of: a polyether diol residue, a polyester diol residue, and a polycarbonate dial residue.
- Example 24 a medical device including a polymeric material. The polymeric material includes a polyisobutylene-polyurethane block copolymer. The polyisobutylene-polyurethane block copolymer includes soft segments, hard segments, and end groups. The soft segments include a polyisobutylene diol residue. The hard segments include a diisocyanate residue. The end groups are bonded by urea bonds to a portion of the diisocyanate residue. The end groups include a residue of a mono-functional amine including a C3 to C30 aliphatic chain.
- Example 25 is the medical device of Example 24, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 26 is the medical device of either of Examples 24 or 25, wherein the mono-functional amine is butylamine.
- Example 27 is the medical device of any of Examples 24-26, wherein the soft segments are present in the copolymer in an amount of about 40% to about 70% by weight of the copolymer, and the hard segments are present in the copolymer in an amount of about 30% to about 60% by weight of the copolymer.
- Example 28 is the medical device of any of Examples 24-27, wherein the diisocyanate residue includes 4,4′-methylene diphenyl diisocyanate residue.
- Example 29 is a method of making a polymeric material. The method includes heating a mixture of soft segment components and hard segment components to an elevated temperature to form a prepolymer, reacting a chain extender with the prepolymer to form a polymer, and reacting an end capping agent with at least one of: the prepolymer and the polymer to form the polymeric material. The soft segment components include a polyisobutylene diol. The hard segment components include a diisocyanate. The end capping agent includes a mono-functional amine including a C3 to C30 aliphatic chain.
- Example 30 is the method of Example 29, wherein the mono-functional amine is a primary amine or a secondary amine.
- Example 31 is the method of either of Examples 29 or 30, wherein the mono-functional amine is butylamine.
- Example 32 is the method of any of Examples 29-31, wherein the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol and the chain extender, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- Example 33 is the method of any of Examples 29-32, wherein heating the mixture of the soft segment components and the hard segment components to an elevated temperature and reacting the chain extender with the heated mixture are in the presence of a tertiary amine catalyst.
- Example 34 is the method of Example 29, wherein the diisocyanate includes 4,4′-methylene diphenyl diisocyanate.
- Example 35 is the method of any of Examples 29-34, wherein the soft segment components further include a polytetramethylene oxide diol, the diisocyanate is in stoichiometric excess with respect to the polyisobutylene diol, the chain extender, and the polytetramethylene oxide diol, and the mono-functional amine is an at least equimolar amount with respect to the diisocyanate.
- While multiple examples are disclosed, still other examples in accordance with this disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
-
FIG. 1 is a schematic diagram illustrating a first step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure. -
FIG. 2 is a schematic diagram illustrating a second step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure. -
FIG. 3 is a schematic diagram illustrating another process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure. -
FIG. 4 is a plot of dynamic viscosity as a function of concentration for polyisobutylene-polyurethane solutions according to some embodiments of this disclosure. - While this disclosure is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the disclosure to the particular embodiments described. On the contrary, this disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure as defined by the appended claims.
- In accordance with various aspects of the disclosure, polyisobutylene-polyurethane block copolymers (also referred to herein collectively as “PIB-PUR”) and methods for making the same are disclosed. Medical devices that can be implantable or insertable into the body of a patient and that comprise a polyisobutylene urethane copolymer are also disclosed. PIB-PUR is a thermoplastic polyurethane (TPUs) that contains hard and soft segments. PIB-PUR is useful in a number of applications, including in medical devices used for insertion or implantation into a patient because they are hydrolytically stable and have good oxidative stability.
- Polyurethanes are a family of copolymers that are synthesized from polyfunctional isocyanates (e.g., diisocyanates, including both aliphatic and aromatic diisocyanates) and polyols (e.g., macroglycols). Commonly employed macroglycols include polyester diols, polyether diols and polycarbonate diols. The macroglycols can form polymeric segments of the polyurethane. Aliphatic or aromatic diols may also be employed as chain extenders, for example, to impart improved physical properties to the polyurethane.
- In some embodiments, the polyisobutylene urethane copolymer includes one or more polyisobutylene segments, one or more segments that includes one or more diisocyanate residues, optionally one or more additional polymeric segments (other than polyisobutylene segments), and optionally one or more chain extenders.
- As used herein, a “polymeric segment” or “segment” is a portion of a polymer. The polyisobutylene segments of the polyisobutylene urethane copolymers are generally considered to constitute soft segments, while the segments containing the diisocyanate residues are generally considered to constitute hard segments. The additional polymeric segments may include soft or hard polymeric segments. As used herein, soft and hard segments are relative terms to describe the properties of polymer materials containing such segments. Without limiting the foregoing, a soft segment may display a glass transition temperature (Tg) that is below body temperature, more typically from 35° C. to 20° C. to 0° C. to −25° C. to −50° C. or below. A hard segment may display a Tg that is above body temperature, more typically from 40° C. to 50° C. to 75° C. to 100° C. or above. Tg can be measured by differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA) and/or thermomechanical analysis (TMA).
- The weight ratio of soft segments to hard segments in the polyisobutylene urethane copolymers of the various embodiments can be varied to achieve a wide range of physical and mechanical properties, and to achieve an array of desirable functional performance. For example, the weight ratio of soft segments to hard segments in the polymer can be varied from 99:1 to 95:5 to 90:10 to 75:25 to 50:50 to 25:75 to 10:90 to 5:95 to 1:99, more particularly from 95:5 to 90:10 to 80:20 to 70:30 to 65:35 to 60:40 to 50:50, and even more particularly, from about 80:20 to about 50:50. In some embodiments, the soft segment components can be about 40% to about 70% by weight of the copolymer, and the hard segment components can be about 30% to about 60% by weight of the copolymer.
- In some embodiments, the copolymer may include polyisobutylene in an amount of about 60% to about 100% by weight of the soft segments and a polyether, a polyester, or a polycarbonate in an amount of about 0% to about 40% by weight of the soft segments. For example, the copolymer may include soft segments in an amount of about 40% to about 70% by weight of the copolymer, of which polyisobutylene is present in an amount of about 60% to about 100% by weight of the soft segments and polyether is present in an amount of about 0% to about 40% by weight of the soft segments. In another embodiment, the copolymer may include soft segments in an amount of about 40% to about 70% by weight of the copolymer, of which polyisobutylene (e.g., a polyisobutylene diol residue) is present in an amount of about 70% to about 95% by weight of the soft segments and a polyether (e.g., polytetramethylene oxide diol residue) is present in an amount of about 5% to about 40% by weight of the soft segments.
- Diisocyanates for use in forming PIB-PUR of the various embodiments include aromatic and non-aromatic (e.g., aliphatic) diisocyanates. Aromatic diisocyanates may be selected from suitable members of the following, among others: 4,4′-methylenediphenyl diisocyanate (MDI), 2,4′-methylenediphenyl diisocyanate (2,4-MDI), 2,4- and/or 2,6-toluene diisocyanate (TDI), 1,5-naphthalene diisocyanate (NDI), para-phenylene diisocyanate, 3,3′-tolidene-4,4′-diisocyanate and 3,3′-dimethyl-diphenylmethane-4,4′-diisocyanate. Non-aromatic diisocyanates may be selected from suitable members of the following, among others: 1,6-hexamethylene diisocyanate (HDI), 4,4′-dicyclohexylmethane diisocyanate (H12-MDI), 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate (isophorone diisocyanate or IPDI), cyclohexyl diisocyanate, and 2,2,4-trimethyl-1,6-hexamethylene diisocyanate (TMDI).
- In some embodiments, a polyether diol such as polytetramethylene oxide diol (PTMO diol), polyhexametheylene oxide diol (PHMO diol), polyoctamethylene oxide diol or polydecamethylene oxide diol, can be combined with a polyisobutylene diol and diisocyanate to form a polyisobutylene polyurethane copolymer. In some embodiments, PIB-PUR may have a generally uniform distribution of polyurethane hard segments, polyisobutylene segments and polyether segments to achieve favorable micro-phase separation in the polymer. In some embodiments, polyether segments may improve key mechanical properties such as Shore hardness, tensile strength, tensile modulus, flexural modulus, elongation tear strength, flex fatigue, tensile creep, and/or abrasion performance, among others.
- The polyisobutylene diol may be a telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with a difunctional initiator compound, such as 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene (hindered dicumyl ether).
- PIB-PUR in accordance with the various embodiments may further include one or more optional chain extender residues. Chain extenders can increase the hard segment length, which can in turn results in a copolymer with a higher tensile modulus, lower elongation at break and/or increased strength.
- Chain extenders can be formed from aliphatic or aromatic diols, in which case a urethane bond is formed upon reaction with an isocyanate group. Chain extenders may be selected from suitable members of the following, among others: 1,4 cyclohexanedimethanol, alpha,omega-alkane diols such as ethylene glycol (1,2-ethane diol), 1,4-butanediol (BDO), and 1,6-hexanediol. Chain extenders may be also selected from suitable members of, among others, short chain diol polymers (e.g., alpha,omega-dihydroxy-terminated polymers having a molecular weight less than or equal to 1000) based on hard and soft polymeric segments (more typically soft polymeric segments) such as those described above, including short chain polyisobutylene diols, short chain polyether polyols such as polytetramethylene oxide diols, short chain polysiloxane diols such as polydimethylsiloxane dials, short chain polycarbonate diols such as polyhexamethylene carbonate diols, short chain poly(fluorinated ether) diols, short chain polyester dials, short chain polyacrylate dials, short chain polymethacrylate dials, and short chain polyvinyl aromatic) dials. Chain extenders may also be selected form suitable glycols, such as propylene glycol, dipropylene glycol, and tripropylene glycol.
- As noted above, it may be desirable to employ solvent-based processing to incorporate a polymeric material, such as PIB-PUR, into an implantable medical device. In some embodiments, the PIB-PUR may be synthesized and stored for a period of time until it is incorporated into the solvent processing. For example, the FIB-PUR may be stored for a period of days, weeks or months. For solvent processing, the PIB-PUR is dissolved in a solvent, such as, for example, 2,6-dimethylpyridine or tetrahydrofuran (THF), to obtain a desired concentration and/or viscosity of the resulting PIB-PUR solution. The PIB-PUR solution can then be deposited onto a substrate, such as a medical device, by electrospraying, electrospinning, spray coating, dip coating, or force spinning.
- It has been found that as PIB-PUR is stored for an extended period of time, on the order of weeks and months, the molecular weight (both the weight average molecular weight (Mw) and the number average molecular weight (Mn)) of the PIB-PUR can increase during the storage period. In some cases, the stored PIB-PUR forms a gel. Such gels are that is no longer easily soluble in 2,6-dimethylpyridine or THF and thus, no longer suitable for solvent-based processing.
- It has been found that, in some embodiments, an end-capping agent that is a mono-functional amine can mitigate the increase in molecular weight due to extended storage time. In addition, it has been found that, in some embodiments, the addition of such an end capping agent to PIB-PUR that has been stored for an extended period of time can reverse the increase in molecular weight of the PIB-PUR. Further, it has been found that the addition of such an end capping agent to PIB-PUR even after is has gelled and is no longer soluble in 2,6-dimethylpyridine or THF can break down the cross-links in the gel so that the PIB-PUR is soluble in 2,6-dimethylpyridine or THF. A gel is defined as a substantially dilute cross-linked system which exhibits no flow when in a steady-state.
- The mono-functional amine can include a C3 to C30 aliphatic chain that can be straight or branched, saturated or unsaturated, a primary amine or a secondary amine. For example, in some embodiments, the mono-functional amine can be a butylamine or a butylamine ether, such as 2-methoxy ethylamine.
-
FIG. 1 is a schematic diagram illustrating a first step of a process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure. A polymeric material including PIB-PUR according to embodiments of this disclosure can be made by mixingsoft segment components 10, includingpolyisobutylene diol 12 and optional polyether diol 14 (PTMO is illustrated), andhard segment component 16, including a diisocyanate 18 (MDI is illustrated), together and heating the mixture to an elevated temperature in the presence of acatalyst 20 to form aprepolymer 22. - An elevated temperature is any temperature above room temperature, such as 30° C., 40° C., 50° C., 60° C., 70° C., 80° C., 90° C., or 100° C., or any temperature between any of the preceding temperatures. The catalyst can be any suitable catalyst, such as, an organometallic catalyst, for example, tin(II) 2-ethylhexanoate (stannous octoate), or a tertiary amine catalyst, for example, 2,6-dimethylpyridine, 1-cyclohexyl-N,N-dimethylmethanamine, N,N,N′,N′,N″-pentamethyldiethylenetriamine, or 4-methylmorpholine, 1-methylimidazole.
- The second step is shown in
FIG. 2 . A chain extender 24 (BDO is illustrated) is reacted at an elevated temperature with theprepolymer 22, along with the mono-functional amine 26 (butylamine is illustrated) in the presence of thecatalyst 20 to form a PIB-PUR 28. As shown inFIG. 2 , the mono-functional amine 26 caps the ends of the PIB-PUR 28, reacting with thediisocyanate 18 to prevent further chain extension. The mono-functional amine 26 may also react withexcess diisocyanate 18 and reduce unwanted side reactions. In some embodiments, the mono-functional amine 26 may be added to theprepolymer 22 at the same time as thechain extender 24. In other embodiments, the mono-functional amine 26 may be added after thechain extender 24 has at least partially reacted with theprepolymer 22 to form a polymer. In some embodiments, the mono-functional amine 26 may be added to theprepolymer 22 at the same time as thechain extender 24 and after thechain extender 24 has at least partially reacted with theprepolymer 22 to form a polymer. - The
diisocyanate 18 can be in stoichiometric excess with respect to thepolyisobutylene diol 12, theoptional polyether diol 14, and thechain extender 24. Thediisocyanate 18 may be in excess to account for diisocyanate lost to reactions with residual water. For example, in some embodiments, thediisocyanate 18 is in excess with respect to thepolyisobutylene diol 12, theoptional polyether 14, and thechain extender 24 by as little as 0.5 mole percent (mol %), 1 mol % 1.5 mol %, or 2 mol %, or as much as 2.5 mol %, 3 mol %, 4 mol %, or 5 mol %, or any value between any two of the preceding values. For example in some embodiments, thediisocyanate 18 is in excess with respect to thepolyisobutylene diol 12, theoptional polyether 14, and thechain extender 24 by from 0.5 mol % to 5 mol %, 1 mol % to 4 mol %, 1.5 mol % to 3 mol %, 2 mol % to 2.5 mol %, or 0.5 mol % to 2.5 mol %. - In some embodiments, the mono-
functional amine 26 can be added in at least equimolar amounts with respect to thediisocyanate 18. In some embodiments, an excess of the mono-functional amine 26 can be added. If necessary, some of the excess mono-functional amine 26 can be removed by heating above the boiling point of the mono-functional amine 26. For example, excess butylamine can be removed by heating above about 78° C., the boiling point of butylamine. - Thus, the PIB-
PUR 28 illustrated inFIG. 2 is a polymeric material including at least soft segments including a residue of thepolyisobutylene diol 12, hard segments including at least residue of thediisocyanate 18, and end groups bonded to some of the diisocyanate residue by a urea bond. The end groups are a residue of the mono-functional amine 26. The hard segments of the embodiment shown inFIG. 2 further include a residue of thechain extender 24. The soft segments of the embodiment shown inFIG. 2 also further include a residue of thepolyether diol 14. In some embodiments, the soft segments can alternatively or additionally include a residue of a polycarbonate diol and/or a polyester diol. -
FIG. 3 is a schematic diagram illustrating another process to produce polyisobutylene-polyurethane according to some embodiments of this disclosure. In the embodiment shown inFIG. 3 , the mono-functional amine 26 (butylamine is shown) is added after the polymerization reaction is at least substantially complete. The polymerization reaction is at least substantially complete when there is no noticeable increase in the viscosity of the polyisobutylene-polyurethane over a period of several hours.FIG. 3 shows a PIB-PUR chain 30 and adiisocyanate residue 32 bonded to a urethane linkage of the PIB-PUR 30 to form anallophanate 34. In some embodiments, the PIB-PUR 30 may have been produced and end-capped with a mono-functional amine as for PIB-PUR 28 described above. In other embodiments, the PIB-PUR 30 may not have been end-capped with a mono-functional amine when initially synthesized. Thediisocyanate residue 32 may be a result of the excess of diisocyanate used to make the PIB-PUR 30 as described above. - Without wishing to be bound by any theory, it is believed that during storing for an extended period of time, the
diisocyanate residue 32 also bonds with other hard or soft segment components, including other chains of the PIB-PUR 30 (not shown), thus cross-linking the other hard or soft segment components to the PIB-PUR 30, increasing the molecular weight of the PIB-PUR 30, and eventually gelling the PIB-PUR 30 as described above. These side reactions can form theallophanate 34. Other side reactions can form other cross-linking structures, such as a biuret (not shown). - The
allophanate 34 is a reversible bond. As noted above, it has been found that the addition of the mono-functional amine 26, even after the PIB-PUR 30 has gelled, reverses the gelling of the PIB-PUR 30 and reduces its molecular weight. Without wishing to be bound by any theory, it is believed that the steric hindrance associated with theallophanate 34 weakens the bond, resulting in the reversible bond shown inFIG. 3 . It is believed that thediisocyanate residue 32 bonds preferentially with the mono-functional amine 26, tying up thediisocyanate residue 32 in a more stable alkyl amine 36 (a butyl amine shown), as shown inFIG. 3 . Tying up the diisocyanate reside 32 may prevent reformation of theallophanate 34 and reduce the cross-linking of the other hard or soft segment components to the PIB-PUR 30, breaking down the gelation of the PIB-PUR 30 and reducing the molecular weight of the PIB-PUR 30. In some embodiments, the molecular weight of the PIB-PUR 30 may be reduced to an initial molecular weight of a linear chain of PIB-PUR 30. - The amine termination of the mono-
functional amine 26 is believed to be well suited to this application, in contrast to, for example, a similarly-structured mono-functional alcohol. It has been found that while the mono-functional amine 26 is effective in reversing gelation of the PIB-PUR 30, a similarly-structured mono-functional alcohol is not effective. - The PIB-
PUR 26 or PIB-PUR 30 according to embodiments of this disclosure can be incorporated into medical devices which can be implanted or inserted into the body of a patient. Example medical devices may include, without limitation, vascular grafts, electrical leads, catheters, leadless cardiac pacemakers (LCP), pelvic floor repair support devices, shock coil coverings, covered stents, urethral stents, internal feeding tubes/balloons, structural heart applications including valve leaflets, suture sleeves, breast implants, ophthalmic applications including intraocular lenses and glaucoma tubes, and spinal disc repair. Example electrical leads may include, without limitation, implantable electrical stimulation or diagnostic systems including neurostimulation systems such as spinal cord stimulation (SCS) systems, deep brain stimulation (DBS) systems, peripheral nerve stimulation (PNS) systems, gastric nerve stimulation systems, cochlear implant systems, and retinal implant systems, among others, and cardiac systems including implantable cardiac rhythm management (CRM) systems, implantable cardioverter-defibrillators (ICD's), and cardiac resynchronization and defibrillation (CRDT) devices, among others. - The present disclosure is more particularly described in the following examples that are intended as illustrations only, since numerous modifications and variations within the scope of the present disclosure will be apparent to those of skill in the art. Unless otherwise noted, all parts, percentages, and ratios reported in the following examples are on a weight bases, and all reagents used in the examples were obtained, or are available, from the chemical suppliers described below, or may be synthesized by conventional techniques.
- Polyisobutylene-polyurethane block copolymer (PIB-PUR) including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle, 106 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-feat-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 72 grams of 4′-methylenediphenyl diisocyanate (MDI), and 56 grams of polytetramethylene oxide diol were dissolved in 545 grams of 2,6-dimethylpyridine. The 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas. The polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole. The solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 16 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- The PIB-PUR was stored at room temperature in a sealed container. After 15 days, the PIB-PUR was characterized by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The PIB-PUR was recharacterized after 63 days and 98 days. The results are shown in Table 1 below. As shown in Table 1 the molecular weight increased, particularly between 64 and 98 days. At 98 days, the PIB-PUR was observed to have gelled. The gelled FIB-FUR was found to be predominantly insoluble in either 2,6-dimethylpyridine or THF, indicating that chemical cross-linking of the PIB-PUR had occurred (the molecular weight was determined from a soluble fraction).
- The gelled PIB-PUR was treated with butylamine in excess equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.5 g of butylamine to 1 g of the gelled PIB-PUR, and then shaking on a shaker table at 225 rpm at 30° C. for about 12 hours. The treated PIB-PUR became a viscous liquid again indicating that whatever chemical cross-linking had taken place appeared to have been reversed with the addition of the butylamine. The treated PIB-PUR solution was recharacterized after 24 hours and after 25 days. The results are also shown in Table 1. As shown in Table 1, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine.
-
TABLE 1 PIB-PUR Mn Mw After 15 days 128,100 286,100 After 63 days 132,200 282,500 After 98 days 213,100 393,100 24 hours after 109,200 259,700 Butylamine Treatment 25 days after 89,600 217,000 Butylamine Treatment - Polyisobutylene-polyurethane block copolymer (PIB-PUR) including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle, 105 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 72 grams of 4′-methylenediphenyl diisocyanate (MDI), and 57 grams of polytetramethylene oxide diol were dissolved in 546 grams of 2,6-dimethylpyridine. The 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas. The polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole. The solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 16 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- The PIB-PUR was stored at room temperature in a sealed container. The PIB-PUR was characterized after 24 days by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The results are shown in Table 2 below.
- The PIB-PUR was treated with butylamine in at least equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.08 g of butylamine to 1 g of the PIB-PUR, and then shaken on a shaker table at 225 rpm at 30° C. for about 12 hours. The treated PIB-PUR solution was stored at room temperature in a sealed container and recharacterized after 24 hours. The results are also shown in Table 2. As shown in Table 2, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine.
-
TABLE 2 PIB-PUR Mn Mw After 24 days 138,700 313,600 24 hours after 51,330 142,500 Butylamine Treatment - A dynamic viscosity was measured for various concentrations of the PIB-PUR of Example 2 in 2,6-dimethylpyridine before
treatment treatment 42 with the butylamine. Three PIB-PUR solutions of various concentrations were prepared for each of the beforetreatment 40 and aftertreatment 42 by adding appropriate amounts of 2,6-dimethylpyridine. The results are shown inFIG. 4 . As shown inFIG. 4 , the dynamic viscosity dropped significantly with the addition of the butylamine, again suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine. - Polyisobutylene-polyurethane block copolymer (PIB-PUR) including soft segments including a polyisobutylene diol residue and hard segments including a diisocyanate residue was prepared as follows. In a 1 liter resin kettle 13 grams of telechelic polyisobutylene diol formed from by carbocationic polymerization beginning with 5-tert-butyl-1,3-bis(1-methoxy-1-methylethyl)benzene, 9 grams of 4′-methylenediphenyl diisocyanate (MDI), and 7 grams of polytetramethylene oxide diol were dissolved in 8 grams of 2,6-dimethylpyridine. The 1 liter resin kettle was equipped with overhead mechanical stirring and was purged with dry nitrogen gas. The polyisobutylene diol had a number average molecular weight (Mn) of 1905 grams/mole and the polytetramethylene oxide diol had a Mn of 1000 grams/mole. The solution was stirred by the overhead mechanical stirrer under the flow of nitrogen gas at a temperature of 60 degrees Celsius while the reagents reacted for 2 hours. After the 2 hours, 2 grams of freshly distilled 1,4-butanediol was added to the solution by dropwise addition and the solution maintained at a temperature of 70 degrees Celsius while the reaction continued for an additional 2 hours. After the additional 2 hours, the solution was highly viscous solution containing the PIB-PUR.
- The PIB-PUR was stored at room temperature in a sealed container. The PIB-PUR was characterized after 21 days by gel permeation chromatography using a multi angle light scattering detector (GPC-MALLS) to determine the number average molecular weight (Mn) and the weight average molecular weight (Mw). The results are shown in Table 3 below.
- The PIB-PUR was treated with butylamine in at least equimolar concentration to the MDI by adding 2,6-dimethylpyridine and 0.08 g of butylamine to 1 g of the PIB-PUR, and then shaken on a shaker table at 225 rpm at 30° C. for about 12 hours. The treated PIB-PUR solution was stored at room temperature in a sealed container and recharacterized after 24 hours and after 17 days. The results are also shown in Table 3. As shown in Table 3, the molecular weight of the treated PIB-PUR decreased significantly with the addition of the butylamine suggesting that at least some of the chemical cross-linking that had taken place over 21 days appeared to have been reversed with the addition of the butylamine. As further shown in Table 3, the cross-links did not reappear over an additional 17 days of storage.
-
TABLE 3 PIB-PUR Mn Mw After 21 days 71,700 184,000 24 hours after 65,970 159,000 Butylamine Treatment 17 days after 61,970 147,800 Butylamine Treatment - A dynamic viscosity was measured for various concentrations of the FIB-FUR of Example 2 in 2,6-dimethylpyridine before
treatment treatment 46 with the butylamine. Three PIB-PUR solutions of various concentrations were prepared for each of the beforetreatment 40 and aftertreatment 42 by adding appropriate amounts of 2,6-dimethylpyridine. The results are shown inFIG. 4 . As shown inFIG. 4 , the dynamic viscosity dropped significantly with the addition of the butylamine, again suggesting that at least some of the chemical cross-linking that had taken place over 24 days appeared to have been reversed with the addition of the butylamine. - Various modifications and additions can be made to the embodiments discussed without departing from the scope of this disclosure. For example, while the embodiments described above refer to particular features, the scope of this disclosure also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of this disclosure is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/951,682 US11851522B2 (en) | 2018-01-17 | 2022-09-23 | End-capped polyisobutylene polyurethane |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862618262P | 2018-01-17 | 2018-01-17 | |
US16/248,498 US11472911B2 (en) | 2018-01-17 | 2019-01-15 | End-capped polyisobutylene polyurethane |
US17/951,682 US11851522B2 (en) | 2018-01-17 | 2022-09-23 | End-capped polyisobutylene polyurethane |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/248,498 Continuation US11472911B2 (en) | 2018-01-17 | 2019-01-15 | End-capped polyisobutylene polyurethane |
Publications (2)
Publication Number | Publication Date |
---|---|
US20230018482A1 true US20230018482A1 (en) | 2023-01-19 |
US11851522B2 US11851522B2 (en) | 2023-12-26 |
Family
ID=66334526
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/248,498 Active 2039-01-27 US11472911B2 (en) | 2018-01-17 | 2019-01-15 | End-capped polyisobutylene polyurethane |
US17/951,682 Active US11851522B2 (en) | 2018-01-17 | 2022-09-23 | End-capped polyisobutylene polyurethane |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/248,498 Active 2039-01-27 US11472911B2 (en) | 2018-01-17 | 2019-01-15 | End-capped polyisobutylene polyurethane |
Country Status (4)
Country | Link |
---|---|
US (2) | US11472911B2 (en) |
EP (1) | EP3740253B1 (en) |
CN (1) | CN111479596B (en) |
WO (1) | WO2019143629A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2385960B1 (en) | 2009-01-12 | 2020-03-11 | University Of Massachusetts Lowell | Polyisobutylene-based polyurethanes |
CN111479596B (en) | 2018-01-17 | 2023-04-07 | 心脏起搏器股份公司 | Blocked polyisobutylene polyurethanes |
Family Cites Families (377)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2240558A (en) | 1936-02-07 | 1941-05-06 | Standard Oil Dev Co | Nitrated diesel fuel and process of making same |
US2182513A (en) | 1936-05-14 | 1939-12-05 | Standard Oil Co | Method of sealing waxy surfaces |
US2202877A (en) | 1937-04-12 | 1940-06-04 | Gulf Oil Corp | Antioxidants and petroleum oils containing the same |
US2451420A (en) | 1943-07-28 | 1948-10-12 | Du Pont | Artificial yarns and process of producing the same |
US2463452A (en) | 1943-08-07 | 1949-03-01 | Du Pont | Adhesive compositions and adhesive sheets |
US3069236A (en) | 1955-03-10 | 1962-12-18 | Aerojet General Co | Method for the preparation of diborane |
US3148028A (en) | 1955-06-24 | 1964-09-08 | Aerojet General Co | Method for the preparation of diborane |
BE635304A (en) | 1962-07-25 | |||
US3328372A (en) | 1964-05-11 | 1967-06-27 | Exxon Research Engineering Co | Soluble high molecular weight polymers of cyclopentadiene |
NL6606553A (en) | 1965-06-18 | 1967-11-13 | ||
BE759829A (en) | 1969-12-03 | 1971-06-03 | Upjohn Co | PREPARATION OF POLYURETHANES |
US3966624A (en) | 1971-07-15 | 1976-06-29 | Sun Oil Company Of Pennsylvania | Blended traction fluid containing hydrogenated polyolefin and an adamantane ether |
US3815611A (en) | 1971-11-26 | 1974-06-11 | Medtronic Inc | Muscle stimulation and/or contraction detection device |
US3755265A (en) | 1972-04-04 | 1973-08-28 | Nasa | Highly fluorinated polyurethanes |
US4118427A (en) | 1973-02-13 | 1978-10-03 | California Institute Of Technology | Curable liquid hydrocarbon prepolymers containing hydroxyl groups and process for producing same |
DE2418075A1 (en) | 1974-04-13 | 1975-10-30 | Bayer Ag | Thermoplastic polyurethane elastomer prepn. - from high mol. wt. polyols, diisocyanates, chain-extending diols and alcohol or amine chain-breakers |
GB1527592A (en) | 1974-08-05 | 1978-10-04 | Ici Ltd | Wound dressing |
US4157430A (en) | 1975-05-05 | 1979-06-05 | The Firestone Tire & Rubber Company | Amine terminated polymers and the formation of block copolymers |
US4157429A (en) | 1975-05-05 | 1979-06-05 | The Firestone Tire & Rubber Company | Amine terminated polymers and the formation of block copolymers |
US4154913A (en) | 1975-05-05 | 1979-05-15 | The Firestone Tire & Rubber Company | Amine terminated polymers and the formation of blocked copolymers |
GB1542319A (en) | 1975-11-26 | 1979-03-14 | Exxon Research Engineering Co | Halogenated organoaluminium catalyst compositions and method of their preparation |
US4145515A (en) | 1976-12-01 | 1979-03-20 | Congoleum Corporation | Method of forming storage-stable polyurethane prepolymers |
US4352359A (en) | 1977-08-19 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Biomedical electrode |
US4230509A (en) | 1979-04-13 | 1980-10-28 | The United States Of America As Represented By The Secretary Of The Army | Pyrophoric flame composition |
US4304771A (en) | 1979-07-13 | 1981-12-08 | Usv Pharmaceutical Corporation | Antihypertensive amides |
US4342849A (en) | 1979-09-10 | 1982-08-03 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
US4316973A (en) | 1979-09-10 | 1982-02-23 | The University Of Akron | Novel telechelic polymers and processes for the preparation thereof |
US4276394A (en) | 1979-09-10 | 1981-06-30 | The University Of Akron | Novel telechelic polymers, block copolymers and processes for the preparation thereof |
US4539996A (en) | 1980-01-23 | 1985-09-10 | Minnesota Mining And Manufacturing Company | Conductive adhesive and biomedical electrode |
US4675361A (en) | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US5120813A (en) | 1980-02-29 | 1992-06-09 | Th. Goldschmidt Ag | Moisture vapor permeable materials |
US4686137A (en) | 1980-02-29 | 1987-08-11 | Thoratec Laboratories Corp. | Moisture vapor permeable materials |
US4861830A (en) | 1980-02-29 | 1989-08-29 | Th. Goldschmidt Ag | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US4423185A (en) | 1980-03-03 | 1983-12-27 | Asahi Kasei Kogyo Kabushiki Kaisha | Thermoplastic resinous composition |
US4425264A (en) | 1981-08-27 | 1984-01-10 | International Flavors & Fragrances Inc. | Branched chain ketones used in augmenting or enhancing the aroma of perfumes, colognes and perfumed articles and the like process for preparing same |
US4374276A (en) | 1981-08-27 | 1983-02-15 | International Flavors & Fragrances Inc. | Novel branched chain ketones and the process for preparing same |
US4430233A (en) | 1981-08-27 | 1984-02-07 | International Flavors & Fragrances Inc. | Branched chain ketones and uses thereof in augmenting or enhancing the aroma of perfumes, colognes and perfumed articles and the process for preparing same |
IL64952A (en) | 1982-02-08 | 1984-12-31 | Bromine Compounds Ltd | Intumescent fire retardant polymer compositions |
US4484586A (en) | 1982-05-27 | 1984-11-27 | Berkley & Company, Inc. | Hollow conductive medical tubing |
US4420411A (en) | 1982-06-04 | 1983-12-13 | International Flavors & Fragrances Inc. | Process for augmenting or enhancing the aroma of detergents using unsaturated branch chain ketones |
US4477604A (en) | 1982-09-20 | 1984-10-16 | Oechsle Iii Sixtus J | Polyurethane compositions and their use as luting agents |
US4570270A (en) | 1982-09-20 | 1986-02-18 | Oechsle Iii Sixtus J | Polyurethane compositions and their use as luting agents |
US4621172A (en) | 1982-12-22 | 1986-11-04 | Nec Corporation | Fast convergence method and system for echo canceller |
US4486572A (en) | 1983-07-06 | 1984-12-04 | University Of Akron | Synthesis of amphiphilic block copolymers and networks |
US4518615A (en) | 1983-08-23 | 1985-05-21 | Warner-Lambert Company | Non-adhesive chewing gum base composition |
ZA841613B (en) | 1984-03-02 | 1984-04-29 | Thiokol Corporation | Radiation curable coating for photographic laminate |
US4508889A (en) | 1984-07-19 | 1985-04-02 | Desoto, Inc. | Preparation of isocyanate-terminated polyurethanes containing amino silanes |
US4767885A (en) | 1984-08-06 | 1988-08-30 | University Of Akron | Sterically hindered binifers telechelic polymers made therefrom |
JPS6173666A (en) | 1984-09-19 | 1986-04-15 | 日本ゼオン株式会社 | Polyurethane excellent in antithrombotic property and dynamical characteristics |
GB2180123B (en) | 1984-12-21 | 1989-01-18 | Senezco Limited | Transponder systems |
US4888389A (en) | 1985-02-05 | 1989-12-19 | University Of Akron | Amphiphilic polymers and method of making said polymers |
US4982038A (en) | 1985-03-19 | 1991-01-01 | Phillips Petroleum Company | Oxidative methylation of organic compounds |
US4600652A (en) | 1985-04-01 | 1986-07-15 | Warner-Lambert Company | Permanently bonded antithrombogenic polyurethane surface |
US4910321A (en) | 1985-06-20 | 1990-03-20 | University Of Akron | Living catalysts, complexes and polymers therefrom |
WO1987004625A1 (en) | 1986-01-30 | 1987-08-13 | Vsesojuzny Nauchno-Issledovatelsky I Ispytatelny I | Polyurethane foam composition for immobilization in traumatology |
US5330520A (en) | 1986-05-15 | 1994-07-19 | Telectronics Pacing Systems, Inc. | Implantable electrode and sensor lead apparatus |
EP0275907A3 (en) | 1987-01-23 | 1989-05-24 | Mobay Corporation | Rim polyurethane or polyurea compositions containing internal mold release agents |
US5017664A (en) | 1987-06-03 | 1991-05-21 | Wisconsin Alumni Research Foundation | Biocompatible polyurethane devices wherein polyurethane is modified with lower alkyl sulfonate and lower alkyl carboxylate |
US4880883A (en) | 1987-06-03 | 1989-11-14 | Wisconsin Alumni Research Foundation | Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate |
EP0295640B1 (en) | 1987-06-18 | 1993-02-03 | Dai-Ichi Kogyo Seiyaku Co., Ltd. | Polyurethane composition |
DE3722680A1 (en) | 1987-07-09 | 1989-01-19 | Leybold Ag | Melting furnace with weight-dependent control of the melting block |
US4752626A (en) | 1987-08-27 | 1988-06-21 | General Motors Corporation | Method of making low compression set urethane foams |
US5000875A (en) | 1987-10-16 | 1991-03-19 | E. I. Du Pont De Nemours And Company | Conductive filled fluoropolymers |
US5149739A (en) | 1988-08-01 | 1992-09-22 | The Bfgoodrich Company | Fiber-reinforced thermoplastic elastomer polyurethane compositions with either modified and/or unmodified polyolefins |
US5171760A (en) | 1988-08-05 | 1992-12-15 | Edison Polymer Innovation Corp. | UV curable polymer formulation |
EP0353471B1 (en) | 1988-08-05 | 1994-01-05 | Edison Polymer Innovation Corporation ( Epic) | UV curable polymer formulation |
IT1227065B (en) | 1988-09-15 | 1991-03-14 | Ausimont Spa | FLUORINATED POLYURETHANE, CONTAINING RUBBER STRUCTURE BLOCKS POLIOS SIPERFLUOROALKYLENE RIGID HYDROGENATED BLOCKS, WITH IMPROVED MECHANICAL PROPERTIES. |
JPH02202908A (en) | 1989-02-02 | 1990-08-13 | Nippon Zeon Co Ltd | Urethane composition |
US4939184A (en) | 1989-03-07 | 1990-07-03 | University Of Akron | Polyurethane foam |
EP0388480A1 (en) | 1989-03-20 | 1990-09-26 | Siemens Aktiengesellschaft | Implantable stimulation electrode |
US5433730A (en) | 1989-05-03 | 1995-07-18 | Intermedics, Inc. | Conductive pouch electrode for defibrillation |
US4928689A (en) | 1989-05-15 | 1990-05-29 | Cardiac Pacemakers, Inc. | Rate adaptive cardiac pacer system having living cell tissue for sensing physiologic demand |
US5029585A (en) | 1989-07-14 | 1991-07-09 | Baxter International Inc. | Comformable intralumen electrodes |
US5194505A (en) | 1989-09-29 | 1993-03-16 | E. I. Du Pont De Nemours And Company | Chlorosulfonated polyolefin-modified polyurethane and polyurea compositions and process for making same |
US5090422A (en) | 1990-04-19 | 1992-02-25 | Cardiac Pacemakers, Inc. | Implantable electrode pouch |
US5282844A (en) | 1990-06-15 | 1994-02-01 | Medtronic, Inc. | High impedance, low polarization, low threshold miniature steriod eluting pacing lead electrodes |
BR9003841A (en) | 1990-08-06 | 1992-02-25 | Sika S A | POLYURETHANE RESIN, ADHESIVE, EPOXY RESIN, PROCESS FOR THE PRODUCTION OF THESE RESINS, INK AND USE |
ES2097169T3 (en) | 1990-08-16 | 1997-04-01 | Basf Ag | PROCEDURE FOR THE OBTAINING OF HYDROCARBONS AND POLYMERS WITH GROUPS CHLORIDE ALILIC TERMINALS. |
JP2969470B2 (en) | 1990-10-18 | 1999-11-02 | 鐘淵化学工業株式会社 | Isobutylene polymer having allyl group at terminal and method for producing the same |
US5129404A (en) | 1990-12-21 | 1992-07-14 | Intermedics, Inc. | Implantable endocardial lead with retractable fixation apparatus |
US5152299A (en) | 1991-04-19 | 1992-10-06 | Intermedics, Inc. | Implantable endocardial lead with spring-loaded screw-in fixation apparatus |
IT1252660B (en) | 1991-12-23 | 1995-06-20 | Ausimont Spa | POLYURETHANE AND POLYURETHANE-UREE FLUORINATED AND PROCESSES FOR THEIR PREPARATION |
DE4244812C2 (en) | 1992-01-25 | 1998-05-28 | Escher Wyss Gmbh | Heated or cooled roller |
EP0625998B1 (en) | 1992-02-10 | 1996-06-05 | Minnesota Mining And Manufacturing Company | Radiation crosslinked elastomers |
US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
US5589563A (en) | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
US5428123A (en) | 1992-04-24 | 1995-06-27 | The Polymer Technology Group | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
US5269810A (en) | 1992-06-19 | 1993-12-14 | W. L. Gore & Associates, Inc. | Patch electrode |
US5324324A (en) | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5322520A (en) | 1992-11-12 | 1994-06-21 | Implemed, Inc. | Iontophoretic structure for medical devices |
US5340881A (en) | 1992-11-16 | 1994-08-23 | The University Of Akron | Aldehyde-telechelic polyisobutylenes, catalytic method for preparing the same with high conversion and selectivity, and block copolymers made thereform |
CA2152604C (en) | 1993-02-01 | 2000-05-09 | Thomas M. Soukup | An implantable electrode |
DE4303556C1 (en) | 1993-02-08 | 1994-10-27 | Bayer Ag | Hard polyurethanes or polyurethane foams |
EP0612538A3 (en) | 1993-02-22 | 1995-04-05 | Cardiac Pacemakers Inc | Metallized, implantable cardiac electrode. |
US5385579A (en) | 1993-03-30 | 1995-01-31 | Siemens Pacesetter, Inc. | Myocardial body implantable lead |
GB9306887D0 (en) | 1993-04-01 | 1993-05-26 | Graham Neil B | Random block copolymers |
JPH06345821A (en) | 1993-04-12 | 1994-12-20 | Kanegafuchi Chem Ind Co Ltd | Production of isobutylene-based polymer having unsaturated group |
US5476496A (en) | 1993-06-01 | 1995-12-19 | Pacesetter Ab | Implantable medical electrode system having an indifferent electrode formed as a part of the electrode insulator sleeve |
JP3418434B2 (en) | 1993-10-07 | 2003-06-23 | 鐘淵化学工業株式会社 | Polymer having terminal functional group and method for producing the same |
WO1995010544A1 (en) | 1993-10-15 | 1995-04-20 | University Of Massachusetts At Lowell | Capping of living polymers |
CA2174246C (en) | 1993-10-29 | 2004-05-11 | Gary R. Schildgen | Method of manufacturing a medical electrical lead |
JPH07330591A (en) | 1994-06-06 | 1995-12-19 | Kanegafuchi Chem Ind Co Ltd | Percutaneously absorbable pharmaceutical preparation |
JPH07331223A (en) | 1994-06-06 | 1995-12-19 | Kanegafuchi Chem Ind Co Ltd | Adhesive composition for medical care |
BE1008706A3 (en) | 1994-09-28 | 1996-07-02 | Cockerill Rech & Dev | Product for the formation of a coating on a support and method of preparation of this product. |
US5442010A (en) | 1994-10-04 | 1995-08-15 | Dow Corning Corporation | Epoxy-terminated polyisobutylene-polydimethylsiloxane compositions |
US5691062A (en) | 1995-02-16 | 1997-11-25 | Clemson University | Molecularly bonded inherently conductive polymers on substrates and shaped articles thereof |
CA2168938C (en) | 1995-03-13 | 2010-06-01 | Wolfgang Kaufhold | A thermoplastic polyurethane resin |
US5559067A (en) | 1995-03-31 | 1996-09-24 | Engelhard Corporation | Modified microsphere FCC catalysts and manufacture thereof |
GB9507393D0 (en) | 1995-04-10 | 1995-05-31 | Bp Chem Int Ltd | Polyolefin diols |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US5639847A (en) | 1995-05-25 | 1997-06-17 | Mearthane Products Corp. | Preparation of conductive polyurethanes using a conductive quasi-solution |
US5630844A (en) | 1995-06-07 | 1997-05-20 | Novamed Medical Products Manufacturing, Inc. | Biocompatible hydrophobic laminate with thermoplastic elastomer layer |
US5681514A (en) | 1995-06-07 | 1997-10-28 | Sulzer Intermedics Inc. | Method for making an implantable conductive lead for use with a cardiac stimulator |
US5663234A (en) | 1995-06-15 | 1997-09-02 | The University Of Akron | Cationic multiblock thermoplastic elastomers |
GB9513713D0 (en) | 1995-07-05 | 1995-09-06 | Exxon Chemical Patents Inc | Curable elastomeric compositions and a process to produce curable elastomeric compositions |
US6369123B1 (en) | 1995-08-14 | 2002-04-09 | 3M Innovative Properties Company | Radiation-crosslinkable elastomers and photocrosslinkers therefor |
US5987746A (en) | 1996-02-21 | 1999-11-23 | Medtronic, Inc. | Method of making medical electrical lead |
DE19610350A1 (en) | 1996-03-15 | 1997-09-18 | Basf Ag | Initiators for the anionically initiated polymerization of monomers having at least one ethylenically unsaturated group |
US5912302A (en) | 1996-06-11 | 1999-06-15 | Gadkari; Avinash Chandrakant | Elastomeric compositions and a process to produce elastomeric compositions |
US5755762A (en) | 1996-06-14 | 1998-05-26 | Pacesetter, Inc. | Medical lead and method of making and using |
US5741331A (en) | 1996-07-29 | 1998-04-21 | Corvita Corporation | Biostable elastomeric polymers having quaternary carbons |
US5665823A (en) | 1996-08-30 | 1997-09-09 | Dow Corning Corporation | Polyisobutylene polymers having acrylic functionality |
US6200589B1 (en) | 1996-09-13 | 2001-03-13 | The University Of Akron | Biological implants of semipermeable amphiphilic membranes |
AUPO251096A0 (en) | 1996-09-23 | 1996-10-17 | Cardiac Crc Nominees Pty Limited | Polysiloxane-containing polyurethane elastomeric compositions |
EP0837097B1 (en) | 1996-10-15 | 1999-08-11 | Advanced Elastomer Systems, L.P. | New block copolymers of polyolefins with polyurethanes, copolyesters or copolyamides and their use |
US5874484A (en) | 1997-01-30 | 1999-02-23 | Shell Oil Company | Use of polyol mixtures in rigid and semi-rigid polyurethane foams |
EP0961796B1 (en) | 1997-01-30 | 2002-05-02 | KRATON Polymers Research B.V. | Use of polyol mixtures in rigid and semi-rigid polyurethane foams |
WO1998033832A1 (en) | 1997-01-30 | 1998-08-06 | Shell Internationale Research Maatschappij B.V. | Use of polyol mixtures in rigid and semi-rigid polyurethane foams |
US5796044A (en) | 1997-02-10 | 1998-08-18 | Medtronic, Inc. | Coiled wire conductor insulation for biomedical lead |
US6117554A (en) | 1997-05-30 | 2000-09-12 | Poly-Med, Inc. | Modulated molecularly bonded inherently conductive polymers on substrates with conjugated multiple lamellae and shaped articles thereof |
US5886089A (en) | 1997-06-04 | 1999-03-23 | Gfx Technologies, Inc. | Grip and friction enhancement compositions |
US6005051A (en) | 1997-08-06 | 1999-12-21 | The University Of Akron | Multi-component polymeric networks containing polyisobutylene |
US6072003A (en) | 1997-08-25 | 2000-06-06 | Advanced Elastomer Systems, L.P. | Block copolymers of polyolefins with polyurethanes, copolyesters or copolyamides and their use |
US20020012694A1 (en) | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
JP3671624B2 (en) | 1997-10-27 | 2005-07-13 | 株式会社カネカ | Polyurethane elastic fiber |
SE510868C2 (en) | 1997-11-03 | 1999-07-05 | Artimplant Dev Artdev Ab | Molds for use as implants in human medicine and a method for making such molds |
US5991667A (en) | 1997-11-10 | 1999-11-23 | Vitatron Medical, B.V. | Pacing lead with porous electrode for stable low threshold high impedance pacing |
US5902329A (en) | 1997-11-14 | 1999-05-11 | Pacesetter, Inc. | Explantable lead |
DE69822270T2 (en) | 1997-11-14 | 2005-01-13 | Sharp K.K. | Method and device for the production of modified particles |
JP3539544B2 (en) | 1998-01-06 | 2004-07-07 | シャープ株式会社 | Surface modification method and surface modified particles |
US6093197A (en) | 1997-12-08 | 2000-07-25 | Axon Engineering, Inc. | Spiral nerve cuff electrode implantation tool |
US5861023A (en) | 1997-12-16 | 1999-01-19 | Pacesetter, Inc. | Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes |
US5931862A (en) | 1997-12-22 | 1999-08-03 | Pacesetter, Inc. | Medical lead and method of making and using with sodium sulfosuccinic ester |
DE19800697B4 (en) | 1998-01-10 | 2009-04-02 | Biotronik Gmbh & Co. Kg | Single electrode probe, especially for implantable defibrillators |
EP1068252B1 (en) | 1998-03-31 | 2005-11-23 | Sekisui Chemical Co., Ltd. | Polyesterurethane elastomers and process for their production |
US6256541B1 (en) | 1998-04-17 | 2001-07-03 | Cardiac Pacemakers, Inc. | Endocardial lead having defibrillation and sensing electrodes with septal anchoring |
US20020138123A1 (en) | 1998-04-21 | 2002-09-26 | Medtronic, Inc. | Medical electrical leads and indwelling catheters with enhanced biocompatibility and biostability |
WO2000013058A1 (en) | 1998-08-26 | 2000-03-09 | Nissan Chemical Industries, Ltd. | Treating agent for liquid crystal alignment layer and liquid crystal device using the same, and method for alignment of liquid crystal |
CN1075103C (en) | 1998-09-21 | 2001-11-21 | 深圳市奥博胶粘剂化工有限公司 | Polyurethane adhesives/sealant composition, precursor and preparation process thereof |
JP2000119363A (en) | 1998-10-13 | 2000-04-25 | Kanegafuchi Chem Ind Co Ltd | Alcoholic hydroxyl-terminated hydrocarbon-based polymer and its production |
US6361780B1 (en) | 1998-11-12 | 2002-03-26 | Cardiac Pacemakers, Inc. | Microporous drug delivery system |
JP4057174B2 (en) | 1998-12-08 | 2008-03-05 | 株式会社カネカ | Adhesive composition and method for producing adhesive product |
JP2000264947A (en) | 1999-03-18 | 2000-09-26 | Asahi Chem Ind Co Ltd | Curable composition |
AU3919500A (en) | 1999-03-23 | 2000-10-09 | Carnegie Wave Energy Limited | Catalytic processes for the controlled polymerization of free radically (co)polymerizable monomers and functional polymeric systems prepared thereby |
JP3795697B2 (en) | 1999-04-20 | 2006-07-12 | 株式会社カネカ | Polyurethane elastic fiber |
US6253110B1 (en) | 1999-04-27 | 2001-06-26 | Medtronic Inc | Method for tissue stimulation and fabrication of low polarization implantable stimulation electrode |
US6869466B2 (en) | 1999-05-07 | 2005-03-22 | Unisearch Limited | Cucurbiturils and method for binding gases and volatiles using cucurbiturils |
EP1061092A1 (en) | 1999-06-17 | 2000-12-20 | Shell Internationale Researchmaatschappij B.V. | Process for the preparation of a rigid polyurethane foam. |
JP2001011319A (en) | 1999-06-30 | 2001-01-16 | Kanegafuchi Chem Ind Co Ltd | Curable composition |
JP2001040064A (en) | 1999-07-30 | 2001-02-13 | Kanegafuchi Chem Ind Co Ltd | Photocurable composition |
US6284682B1 (en) | 1999-08-26 | 2001-09-04 | The University Of British Columbia | Process for making chemically bonded sol-gel ceramics |
US6363286B1 (en) | 1999-09-24 | 2002-03-26 | Cardiac Pacemakers, Inc. | High impedance electrode assembly |
JP2001131879A (en) | 1999-10-25 | 2001-05-15 | Kanegafuchi Chem Ind Co Ltd | Artificial leather |
JP4154815B2 (en) | 1999-10-28 | 2008-09-24 | ぺんてる株式会社 | Bar code reader |
US6228945B1 (en) | 1999-12-20 | 2001-05-08 | The University Of Akron | Three arm star compositions of matter having diblock arms based on polyisobutylene and methods of preparation |
US20010021743A1 (en) | 1999-12-28 | 2001-09-13 | Yuichiro Wakana | Method of producing a graft copolymer |
EP1275670B1 (en) | 2000-01-21 | 2005-08-10 | Mitsui Chemicals, Inc. | Olefin block copolymers, production processes of the same and use thereof |
US6426114B1 (en) | 2000-05-02 | 2002-07-30 | The University Of British Columbia | Sol-gel calcium phosphate ceramic coatings and method of making same |
US7013182B1 (en) | 2000-05-04 | 2006-03-14 | Cardiac Pacemakers, Inc. | Conductive polymer sheath on defibrillator shocking coils |
US6242058B1 (en) | 2000-05-12 | 2001-06-05 | Dow Corning Corporation | Method for forming coatings from radiation curable compositions containing alkenyl ether functional polyisobutylenes |
US6703433B1 (en) | 2000-05-12 | 2004-03-09 | Dow Corning Corporation | Radiation curable compositions containing alkenyl ether functional polyisobutylenes |
CN1443147A (en) | 2000-05-19 | 2003-09-17 | 英属哥伦比亚大学 | Process for making chemically bonded composite hydroxide ceramics |
US6555619B1 (en) | 2000-06-29 | 2003-04-29 | The University Of Akron | Physically crosslinked amphiphilic networks, methods of preparation, and uses thereof |
WO2002013785A2 (en) | 2000-08-14 | 2002-02-21 | Pharmacia Corporation | Drug delivery system with burst electrode |
CN1234756C (en) | 2000-10-18 | 2006-01-04 | 三井化学株式会社 | Foam of thermoplastic urethane elastomer composition and process for producing the foam |
TW541853B (en) | 2000-11-10 | 2003-07-11 | Sumitomo Chemical Co | Polymeric fluorescent substance and polymer light-emitting device using the same |
US6533955B1 (en) | 2000-11-20 | 2003-03-18 | 3M Innovative Properties Company | Conductive fluoropolymers |
US6545097B2 (en) | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
JP3785931B2 (en) | 2000-12-28 | 2006-06-14 | 日本電気株式会社 | I / O request blocking method, I / O request blocking method, and recording medium recording I / O request blocking program |
US6704604B2 (en) | 2000-12-28 | 2004-03-09 | Medtronic, Inc. | System and method for promoting selective tissue in-growth for an implantable medical device |
JP3808758B2 (en) | 2001-03-22 | 2006-08-16 | 株式会社カネカ | Method for producing isobutylene polymer |
US7396582B2 (en) | 2001-04-06 | 2008-07-08 | Advanced Cardiovascular Systems, Inc. | Medical device chemically modified by plasma polymerization |
US6730324B2 (en) | 2001-04-20 | 2004-05-04 | The University Of British Columbia | Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
US7589132B2 (en) | 2001-05-01 | 2009-09-15 | Pentron Clinical Technologies, Llc | Dental resins, dental composite materials, and method of manufacture thereof |
US6653365B2 (en) | 2001-05-01 | 2003-11-25 | Pentron Clinical Technologies, Llc | Dental composite materials and method of manufacture thereof |
US7160941B2 (en) | 2001-05-01 | 2007-01-09 | Pentron Clinical Technologies, Llc | Dental composite materials and method of manufacture thereof |
US7470728B2 (en) | 2001-05-01 | 2008-12-30 | Pentron Clinical Technologies Llc | Dental glazes and method of manufacture and use thereof |
ITMI20011306A1 (en) | 2001-06-21 | 2002-12-21 | Ausimont Spa | VULCANIZABLE POLYURETHANE |
US7363091B1 (en) | 2001-07-11 | 2008-04-22 | Pacesetter Inc. | Method of molding silicone elastomer drug carrier in an endocardial lead |
US6600956B2 (en) | 2001-08-21 | 2003-07-29 | Cyberonics, Inc. | Circumneural electrode assembly |
US6852794B2 (en) | 2001-09-07 | 2005-02-08 | The Goodyear Tire & Rubber Company | Rubber compound containing a polyhedral oligomeric silsesquioxanes |
IN2014DN10834A (en) | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US20030073961A1 (en) | 2001-09-28 | 2003-04-17 | Happ Dorrie M. | Medical device containing light-protected therapeutic agent and a method for fabricating thereof |
JP3969058B2 (en) | 2001-10-31 | 2007-08-29 | 東ソー株式会社 | Method for producing flexible polyurethane foam |
US7187980B2 (en) | 2001-11-09 | 2007-03-06 | Oscor Inc. | Cardiac lead with steroid eluting ring |
WO2003042273A1 (en) | 2001-11-14 | 2003-05-22 | Medtronic, Inc. | Compounds containing quaternary carbons, medical devices, and methods |
EP1446437B1 (en) | 2001-11-14 | 2015-04-15 | Medtronic, Inc. | Compounds containing quaternary carbons, medical devices, and methods |
US6709514B1 (en) | 2001-12-28 | 2004-03-23 | Advanced Cardiovascular Systems, Inc. | Rotary coating apparatus for coating implantable medical devices |
DE10206123A1 (en) * | 2002-02-14 | 2003-09-04 | Wacker Chemie Gmbh | Textile structures comprising organopolysiloxane / polyurea / polyurethane block copolymer |
US6777026B2 (en) | 2002-10-07 | 2004-08-17 | Lord Corporation | Flexible emissive coatings for elastomer substrates |
US7196142B2 (en) | 2002-04-04 | 2007-03-27 | The University Of Akron | Polyisobutylene-based block anionomers and cationomers and synthesis thereof |
US20030236513A1 (en) | 2002-06-19 | 2003-12-25 | Scimed Life Systems, Inc. | Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
US7292890B2 (en) | 2002-06-20 | 2007-11-06 | Advanced Bionics Corporation | Vagus nerve stimulation via unidirectional propagation of action potentials |
AUPS318202A0 (en) | 2002-06-26 | 2002-07-18 | Cochlear Limited | Parametric fitting of a cochlear implant |
US20040039437A1 (en) | 2002-08-13 | 2004-02-26 | Medtronic, Inc. | Medical device exhibiting improved adhesion between polymeric coating and substrate |
US7438925B2 (en) | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
DE10241853B3 (en) | 2002-09-09 | 2004-01-22 | Byk-Chemie Gmbh | Polymeric urea urethane as a rheology control agent and manufacturing process |
ATE406397T1 (en) | 2002-09-17 | 2008-09-15 | Medtronic Inc | COMPOUNDS CONTAINING QUARTERNARY CARBON AND SILICON GROUPS, MEDICAL DEVICES AND METHODS |
US20040063805A1 (en) | 2002-09-19 | 2004-04-01 | Pacetti Stephen D. | Coatings for implantable medical devices and methods for fabrication thereof |
US6770729B2 (en) | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US7231259B2 (en) | 2002-10-04 | 2007-06-12 | Pacesetter, Inc. | Body implantable lead comprising electrically conductive polymer conductors |
HUP0203632A3 (en) | 2002-10-25 | 2005-08-29 | Furukawa Electric Technologiai | Recyclable crosslinked polymers with saturated main chain and thermally reversible urethane crosslink points |
CA2505821C (en) | 2002-11-12 | 2012-08-21 | The Polymer Technology Group Incorporated | Control of polymer surface molecular architecture via amphipathic endgroups |
US6896965B1 (en) | 2002-11-12 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Rate limiting barriers for implantable devices |
JP4160379B2 (en) | 2002-12-26 | 2008-10-01 | 株式会社カネカ | Thermoplastic elastomer composition |
US20050043585A1 (en) | 2003-01-03 | 2005-02-24 | Arindam Datta | Reticulated elastomeric matrices, their manufacture and use in implantable devices |
US8016752B2 (en) | 2003-01-17 | 2011-09-13 | Gore Enterprise Holdings, Inc. | Puncturable catheter |
US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
US20040147994A1 (en) | 2003-01-28 | 2004-07-29 | Cardiac Pacemakers, Inc. | Tachy lead system optimized for septal placement |
DE10303275A1 (en) | 2003-01-28 | 2004-07-29 | Basf Ag | Functionalization of isobutene polymers, useful for the production of polyurethanes, comprises reaction of at least one isobutene polymer having terminal unsaturation with a hydroboration agent |
US20050079199A1 (en) | 2003-02-18 | 2005-04-14 | Medtronic, Inc. | Porous coatings for drug release from medical devices |
US20080051866A1 (en) | 2003-02-26 | 2008-02-28 | Chao Chin Chen | Drug delivery devices and methods |
US6926919B1 (en) | 2003-02-26 | 2005-08-09 | Advanced Cardiovascular Systems, Inc. | Method for fabricating a coating for a medical device |
US7172575B2 (en) | 2003-03-05 | 2007-02-06 | Advanced Cardiovascular Systems, Inc. | Catheter balloon having a lubricious coating |
US20040186545A1 (en) | 2003-03-20 | 2004-09-23 | Rosero Spencer Z. | Temporary percutaneous cardioverter-defibrillator |
US7065411B2 (en) | 2003-04-23 | 2006-06-20 | Medtronic, Inc. | Electrical medical leads employing conductive aerogel |
GB0311121D0 (en) | 2003-05-15 | 2003-06-18 | Avecia Ltd | Polyurethane dispersants |
US20050060022A1 (en) | 2003-05-21 | 2005-03-17 | Felt Jeffrey C. | Polymer stent |
WO2004114732A1 (en) | 2003-06-19 | 2004-12-29 | World Properties, Inc. | Material including a liquid crystalline polymer and a polyhedral oligomeric silsesquioxane (poss) filler |
US6969744B2 (en) | 2003-06-19 | 2005-11-29 | University Of Southern Mississippi | Living and quasiliving cationic telechelic polymers quenched by N-substituted pyrrole and methods for their preparation |
CA2529420A1 (en) | 2003-06-20 | 2004-12-29 | Rudolf Faust | End-capped polymer chains and products thereof |
DE10328854A1 (en) | 2003-06-26 | 2005-01-13 | Basf Ag | Process for the preparation of polyisobutenes |
EP1639024A4 (en) | 2003-07-01 | 2008-03-12 | Univ Akron Akron Ohio | Thermoplastic elastomeric multiblock copolymers of isobutylene and norbornene |
US7364585B2 (en) | 2003-08-11 | 2008-04-29 | Boston Scientific Scimed, Inc. | Medical devices comprising drug-loaded capsules for localized drug delivery |
KR100579007B1 (en) | 2003-08-13 | 2006-05-12 | 주식회사 루밴틱스 | Photocurable and antistatic resin composition for optical fiber coating |
US7953499B2 (en) | 2003-09-30 | 2011-05-31 | Cardiac Pacemakers, Inc. | Drug-eluting electrode |
US20050080470A1 (en) | 2003-10-09 | 2005-04-14 | Randy Westlund | Intramyocardial lead implantation system and method |
GB0323733D0 (en) | 2003-10-10 | 2003-11-12 | Univ Heriot Watt | Conductive polymer |
GB0326286D0 (en) | 2003-11-11 | 2003-12-17 | Vantico Gmbh | Initiator systems for polymerisable compositions |
US7807722B2 (en) | 2003-11-26 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Biobeneficial coating compositions and methods of making and using thereof |
US7119138B1 (en) | 2003-12-19 | 2006-10-10 | Inmat Inc. | Barrier coating of a mixture of cured and uncured elastomeric polymers and a dispersed layered filler in a liquid carrier and coated articles |
GB0401202D0 (en) | 2004-01-20 | 2004-02-25 | Ucl Biomedica Plc | Polymer for use in conduits and medical devices |
GB2427408A (en) | 2004-01-20 | 2006-12-27 | World Properties Inc | Circuit Materials Circuits Multi Layer Circuits And Method Of Manufacture |
US7280875B1 (en) | 2004-02-04 | 2007-10-09 | Pacesetter, Inc. | High strength, low resistivity electrode |
US7056985B2 (en) | 2004-02-11 | 2006-06-06 | University Of Massachusetts Lowell | End-capped polymer chains and products thereof |
US20050180919A1 (en) | 2004-02-12 | 2005-08-18 | Eugene Tedeschi | Stent with radiopaque and encapsulant coatings |
US20070190108A1 (en) | 2004-05-17 | 2007-08-16 | Arindam Datta | High performance reticulated elastomeric matrix preparation, properties, reinforcement, and use in surgical devices, tissue augmentation and/or tissue repair |
US7105622B2 (en) | 2004-06-02 | 2006-09-12 | The University Of Akron | Hybrid polyurethanes |
US20050288476A1 (en) | 2004-06-17 | 2005-12-29 | Iskender Yilgor | Thermoplastic copolymers through stoichiometric reactions between diisocyanates and oligomeric diols and diamines |
CA2471006A1 (en) | 2004-06-23 | 2005-12-23 | Bayer Inc. | Silica reinforced elastomer compounds prepared with dry liquid modifiers |
JP2006274235A (en) | 2004-07-30 | 2006-10-12 | Fuji Photo Film Co Ltd | Polymerizable composition, optically anisotropic layer, method for producing the same, optical compensatory element, liquid crystal display and liquid crystal projector |
JP4155243B2 (en) | 2004-08-04 | 2008-09-24 | トヨタ自動車株式会社 | Solenoid valve |
US20060047083A1 (en) | 2004-08-30 | 2006-03-02 | Iskender Yilgor | Triblock copolymers and their production methods |
US7289856B1 (en) | 2004-09-29 | 2007-10-30 | Pacesetter, Inc. | Medical electrical lead containing a pyroelectric material |
US7347751B2 (en) | 2004-09-30 | 2008-03-25 | Cardiac Pacemakers, Inc. | Cardiac lead implantation system |
DE102004048991B4 (en) | 2004-10-04 | 2010-01-28 | Biotronik Crm Patent Ag | electrode line |
GB0428444D0 (en) | 2004-12-29 | 2005-02-02 | Cambridge Display Tech Ltd | Conductive polymer compositions in opto-electrical devices |
US8075906B2 (en) | 2005-02-01 | 2011-12-13 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species |
WO2006110647A1 (en) | 2005-04-08 | 2006-10-19 | University Of Massachusetts Lowell Research Foundation | Capping reactions in cationic polymerization; kinetic and synthetic utility |
US20060235499A1 (en) | 2005-04-14 | 2006-10-19 | Cardiac Pacemakers, Inc. | Coated lead fixation electrode |
US20060249446A1 (en) | 2005-05-04 | 2006-11-09 | Gary Yeager | Solvent-resistant composite membrane composition |
US20070051531A1 (en) | 2005-09-08 | 2007-03-08 | Harshad Borgaonkar | Drug eluting coatings for a medical lead and method therefor |
US7630749B2 (en) | 2005-11-07 | 2009-12-08 | Gore Enterprise Holdings, Inc. | Implantable electrophysiology lead body |
US7553546B1 (en) | 2005-11-16 | 2009-06-30 | Pacesetter, Inc. | Polyethylene oxide and silicone copolymers and their usage on medical devices |
US7715922B1 (en) | 2005-11-16 | 2010-05-11 | Pacesetter, Inc. | Polyethylene oxide and polyisobutylene copolymers and their usage on medical devices |
US8034874B2 (en) | 2005-11-23 | 2011-10-11 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions that contain fluorocarbon-containing block copolymers |
US20070122361A1 (en) | 2005-11-29 | 2007-05-31 | Weitao Jia | Tooth colorant and whitener, method of manufacture, and method of use thereof |
US20070128246A1 (en) | 2005-12-06 | 2007-06-07 | Hossainy Syed F A | Solventless method for forming a coating |
US20070142560A1 (en) | 2005-12-21 | 2007-06-21 | Young-Ho Song | Block copolymer particles |
US7501179B2 (en) | 2005-12-21 | 2009-03-10 | Boston Scientific Scimed, Inc. | Block copolymer particles |
US20070190104A1 (en) | 2006-02-13 | 2007-08-16 | Kamath Kalpana R | Coating comprising an adhesive polymeric material for a medical device and method of preparing the same |
US7981509B2 (en) | 2006-02-13 | 2011-07-19 | Donaldson Company, Inc. | Polymer blend, polymer solution composition and fibers spun from the polymer blend and filtration applications thereof |
US7465777B2 (en) | 2006-03-02 | 2008-12-16 | Boston Scientific Scimed, Inc. | Hybrid polymer materials from reactive extrusion for medical devices |
USD579758S1 (en) | 2006-03-23 | 2008-11-04 | Ykk Ap Inc. | Sash lock |
US7881808B2 (en) | 2006-03-29 | 2011-02-01 | Cardiac Pacemakers, Inc. | Conductive polymeric coating with optional biobeneficial topcoat for a medical lead |
US7737060B2 (en) | 2006-03-31 | 2010-06-15 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US20070282411A1 (en) | 2006-03-31 | 2007-12-06 | Brian Franz | Compliant electrical stimulation leads and methods of fabrication |
WO2007117566A2 (en) | 2006-04-07 | 2007-10-18 | University Of Massachusetts Lowell | Method to prepare block copolymers by the combination of cationic and anionic polymerization |
EP2006328A4 (en) | 2006-04-13 | 2011-03-02 | Kaneka Corp | Composition for rubber stoppers and rubber stoppers for medical use |
US7689291B2 (en) | 2006-05-01 | 2010-03-30 | Cardiac Pacemakers, Inc. | Lead with fibrous matrix coating and methods related thereto |
US7727541B2 (en) | 2006-05-18 | 2010-06-01 | Boston Scientific Scimed, Inc. | Medical devices having polymeric regions based on vinyl ether block copolymers |
US7951194B2 (en) | 2006-05-26 | 2011-05-31 | Abbott Cardiovascular Sysetms Inc. | Bioabsorbable stent with radiopaque coating |
EP2022512A4 (en) | 2006-05-31 | 2012-09-05 | Kaneka Corp | Catheter tube and catheter comprising the tube |
US20080095918A1 (en) | 2006-06-14 | 2008-04-24 | Kleiner Lothar W | Coating construct with enhanced interfacial compatibility |
US9011516B2 (en) | 2006-06-20 | 2015-04-21 | Boston Scientific Scimed, Inc. | Medical devices including composites |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
DE102006037582A1 (en) | 2006-08-11 | 2008-02-14 | Bayer Materialscience Ag | Antistatic and electrically conductive polyurethanes |
US20080108773A1 (en) | 2006-11-06 | 2008-05-08 | Wicks Douglas A | Polyurethane dispersions containing POSS nanoparticles |
EP2094738B1 (en) | 2006-11-17 | 2013-02-27 | University Of Massachusetts Lowell Research Foundation | Functional hydrocarbon polymers and process for producing same |
US8163826B2 (en) | 2006-11-21 | 2012-04-24 | Schlumberger Technology Corporation | Polymeric acid precursor compositions and methods |
US20080124555A1 (en) | 2006-11-29 | 2008-05-29 | 3M Innovative Properties Company | Polymerizable composition comprising perfluoropolyether urethane having ethylene oxide repeat units |
CN105628897A (en) | 2006-11-30 | 2016-06-01 | 阿克伦大学 | Polyisobutylenes and process for making same |
US20160024340A1 (en) | 2006-12-14 | 2016-01-28 | Ppg Industries Ohio, Inc. | Polyurethanes, articles and coatings prepared therefrom and methods of making the same |
US20080167710A1 (en) | 2007-01-05 | 2008-07-10 | Vipul Bhupendra Dave | Medical Device Having Regions With Various Agents Dispersed Therein and a Method for Making the Same |
US20080175881A1 (en) | 2007-01-18 | 2008-07-24 | Boston Scientific Scimed, Inc. | Blood-contacting medical devices for the release of nitric oxide and anti-restenotic agents |
US20080194736A1 (en) | 2007-02-13 | 2008-08-14 | Minqiu Lu | PVC nanocomposite manufacturing technology and applications |
US20080208325A1 (en) | 2007-02-27 | 2008-08-28 | Boston Scientific Scimed, Inc. | Medical articles for long term implantation |
CA2680321C (en) | 2007-03-09 | 2016-05-03 | The University Of Akron | Bio-artificial pancreas and a procedure for preparation of same |
US8409348B2 (en) | 2007-03-16 | 2013-04-02 | Ube Industries, Ltd. | Production method of zinc oxide single crystal |
JP2008238761A (en) | 2007-03-29 | 2008-10-09 | Toyoda Gosei Co Ltd | Polyurethane material and its manufacturing method |
CA2683844C (en) | 2007-04-12 | 2015-06-02 | Joseph P. Kennedy | Injectible cyanoacrylate-functionalized polyisobutylenes |
CN101809062B (en) | 2007-06-19 | 2014-05-28 | 阿克伦大学 | Singly-terminated polyisobutylenes and process for making same |
WO2009051945A1 (en) | 2007-10-15 | 2009-04-23 | Cardiac Pacemakers, Inc. | Conductive composite electrode material |
CA2704508A1 (en) | 2007-11-01 | 2009-05-07 | The University Of Akron | Thermoplastic amphiphilic co-networks |
JP2009132832A (en) | 2007-11-30 | 2009-06-18 | Asahi Glass Co Ltd | One-component type polyurethane-based curable composition and adhesive using this |
US20090156772A1 (en) | 2007-12-12 | 2009-06-18 | Boston Scientific Scimed, Inc. | Melt processed materials for medical articles |
FR2925061B1 (en) | 2007-12-18 | 2010-01-15 | Michelin Soc Tech | RUBBER COMPOSITION, IN PARTICULAR FOR THE MANUFACTURE OF TIRES |
FR2925062B1 (en) | 2007-12-18 | 2011-03-04 | Michelin Soc Tech | RUBBER COMPOSITION, IN PARTICULAR FOR THE MANUFACTURE OF TIRES |
US8349123B2 (en) | 2008-04-01 | 2013-01-08 | Henkel Corporation | High heat resistant adhesive and sealant compositions |
US20090292094A1 (en) | 2008-05-21 | 2009-11-26 | E. I. Dupont De Nemours And Company | Fluoropolymer Composition |
US8452258B2 (en) | 2008-06-20 | 2013-05-28 | Movirtu Limited | Method and system to implement telephone billing to incentivize shared mobile phone usage |
US20090326077A1 (en) | 2008-06-27 | 2009-12-31 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical devices containing the same |
WO2010033359A1 (en) | 2008-09-19 | 2010-03-25 | Cardiac Pacemakers, Inc. | Surface modification to improve lubricity, abrasion resistance and temperature resilience of leads |
US20110213084A1 (en) | 2008-10-01 | 2011-09-01 | The University Of Akron | Polymers having both hard and soft segments, and process for making same |
CN102341134B (en) * | 2008-12-31 | 2014-09-10 | 波士顿科学医学有限公司 | Copolymers having polyisobutylene and biodegradable polymer segments |
US8285396B2 (en) | 2009-01-05 | 2012-10-09 | Kenergy, Inc. | MRI compatible electrical lead for an implanted electronic medical device |
EP2385960B1 (en) | 2009-01-12 | 2020-03-11 | University Of Massachusetts Lowell | Polyisobutylene-based polyurethanes |
AU2010226254B2 (en) | 2009-03-17 | 2013-08-29 | Cardiac Pacemakers, Inc. | Porous fiber electrode coating and related methods |
US8765238B2 (en) | 2009-03-18 | 2014-07-01 | Boston Scientific Scimed, Inc. | Polymeric/inorganic composite materials for use in medical devices |
US8155759B2 (en) | 2009-03-20 | 2012-04-10 | Innovia, Llc | Pacemaker lead and method of making same |
WO2010111280A1 (en) | 2009-03-23 | 2010-09-30 | University Of Massachusetts Lowell | Functional polysobutylene based macromonomers and methods for making and using the same |
EP2432513A2 (en) | 2009-05-21 | 2012-03-28 | Boston Scientific Scimed, Inc. | Implantable medical devices for therapeutic agent delivery |
EP2467174B1 (en) | 2009-08-21 | 2018-09-26 | Cardiac Pacemakers, Inc. | Crosslinkable polyisobutylene-based polymers and medical devices containing the same |
US20110051581A1 (en) | 2009-08-25 | 2011-03-03 | Seagate Technology Llc | Vibration analysis methodology using data storage devices |
US8644952B2 (en) | 2009-09-02 | 2014-02-04 | Cardiac Pacemakers, Inc. | Medical devices including polyisobutylene based polymers and derivatives thereof |
US8374704B2 (en) | 2009-09-02 | 2013-02-12 | Cardiac Pacemakers, Inc. | Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same |
EP2499200A4 (en) | 2009-11-11 | 2014-04-30 | Univ Akron | Polyisobutylene-based polyurethanes, polyureas and/or polyurethane-polyureas and method for making same |
US20110152989A1 (en) * | 2009-12-23 | 2011-06-23 | Pacesetter, Inc. | Soft abrasion-resistant polyisobutylene urethane copolymers |
CN102741365A (en) | 2010-01-21 | 2012-10-17 | 太阳化学公司 | Low VOC solvent systems |
WO2011127181A2 (en) | 2010-04-06 | 2011-10-13 | Syracuse University | System and method for the release of nitric oxide using nanoscale media |
WO2011133847A2 (en) | 2010-04-22 | 2011-10-27 | Syracuse University | Polyhedral oligomeric silsesquioxane polyurethanes |
FR2962368B1 (en) | 2010-07-09 | 2012-08-31 | Michelin Soc Tech | PNEUMATIC OBJECT COMPRISING A GAS-SEALED LAYER BASED ON A MIXTURE OF A BUTYL RUBBER AND A THERMOPLASTIC ELASTOMER |
US9611368B2 (en) | 2010-10-15 | 2017-04-04 | Evoqua Water Technologies Llc | Process for making a monomer solution for making cation exchange membranes |
EP3626341B1 (en) | 2010-10-15 | 2021-06-09 | Evoqua Water Technologies LLC | Anion exchange membranes and process for making |
BR112013010666B1 (en) | 2010-11-11 | 2021-01-19 | Dow Global Technologies Llc | method for producing an insulating glass sealing unit based on polyurethane and insulating glass sealing unit based on polyurethane |
JP5739007B2 (en) | 2010-12-20 | 2015-06-24 | カーディアック ペースメイカーズ, インコーポレイテッド | Lead having conductive polymer conductor and method of manufacturing the same |
JP5742226B2 (en) | 2011-01-04 | 2015-07-01 | 凸版印刷株式会社 | Gas barrier laminate, production method thereof, and gas barrier laminate film |
WO2012116164A2 (en) | 2011-02-23 | 2012-08-30 | The University Of Akron | Melt processible polyureas and polyurea-urethanes, method for the production thereof and products made therefrom |
US20130041108A1 (en) | 2011-05-19 | 2013-02-14 | Joseph P. Kennedy | Polymers having both hard and soft segments, and process for making same |
WO2013003838A1 (en) | 2011-06-30 | 2013-01-03 | The University Of Akron | Method for the synthesis of low cost initiators for telechelic polyisobutylenes |
WO2013005004A1 (en) | 2011-07-02 | 2013-01-10 | Ucl Business Plc | Implantable small diameter drainage conduit |
JP2014525279A (en) | 2011-08-12 | 2014-09-29 | カーディアック ペースメイカーズ, インコーポレイテッド | Method for coating devices using electrospinning and meltblowing methods |
US9593271B2 (en) | 2011-09-22 | 2017-03-14 | Kaneka Corporation | Curable composition and cured product thereof |
CN102304679B (en) | 2011-09-28 | 2013-01-30 | 宋玉军 | Amorphous nanocrystal gradient functional material and preparation method thereof |
WO2013055977A1 (en) | 2011-10-13 | 2013-04-18 | The Research Foundation Of State University Of New York | Polymeric heart valve |
FR2981937B1 (en) | 2011-10-28 | 2013-11-08 | Michelin Soc Tech | ELASTOMERIC COMPOSITION HAVING VERY GOOD DISPERSION OF THE LOAD IN THE ELASTOMERIC MATRIX |
US20130131765A1 (en) | 2011-11-23 | 2013-05-23 | Jeannette C. Polkinghorne | Fibrous matrix coating materials |
CN103987531A (en) | 2011-12-12 | 2014-08-13 | 米其林集团总公司 | Elastomeric composition having very good dispersion of the filler in the elastomeric matrix |
FR2984340B1 (en) | 2011-12-16 | 2018-01-12 | Soc Tech Michelin | TIRE HAVING AN EXTERNAL FLAN BASED ON A MIXTURE OF DIENE ELASTOMER AND THERMOPLASTIC ELASTOMER |
FR2984339B1 (en) | 2011-12-16 | 2018-01-12 | Soc Tech Michelin | PNEUMATIC HAVING A TREAD LINE BASED ON A MIXTURE OF DIENE ELASTOMER AND THERMOPLASTIC ELASTOMER |
FR2984335B1 (en) | 2011-12-16 | 2018-01-12 | Societe De Technologie Michelin | TIRE COMPRISING INTERNAL LAYER BASED ON A MIXTURE OF DIENE ELASTOMER AND THERMOPLASTIC ELASTOMER |
JP5879146B2 (en) | 2012-02-16 | 2016-03-08 | 積水化成品工業株式会社 | Electrode pad |
US8816028B2 (en) | 2012-05-22 | 2014-08-26 | Petrochemical Supply, Inc. | Polyisobutylene composition having internal vinylidene and process for preparing the polyisobutylene polymer composition |
PL3533792T3 (en) | 2012-06-07 | 2021-11-29 | Aragon Pharmaceuticals, Inc. | Crystalline forms of an androgen receptor modulator |
EP2875071A4 (en) * | 2012-07-23 | 2015-12-23 | Univ Akron | Polyisobutylene-based polyurethanes containing organically modified montmorillonite |
EP2895309B1 (en) | 2012-09-11 | 2017-04-26 | Cardiac Pacemakers, Inc. | Method of forming an implantable medical device and medical electrical lead. |
US20140096964A1 (en) | 2012-10-10 | 2014-04-10 | Baker Hughes Incorporated | Nanoparticle modified fluids and methods of manufacture thereof |
EP2922888B1 (en) | 2012-11-21 | 2021-08-18 | The University of Massachusetts | High strength polyisobutylene polyurethanes |
USD689734S1 (en) | 2013-02-22 | 2013-09-17 | Hamilton Beach Brands, Inc. | Food processor |
US9604281B2 (en) | 2013-03-13 | 2017-03-28 | Syracuse University | Method to control void formation in nanomaterials using core/alloy nanoparticles with stainless interfaces |
US9133394B2 (en) | 2013-03-14 | 2015-09-15 | Nanosys, Inc. | Polyhedral oligomeric silsesquioxane nanocrystal stabilization ligands |
US9688791B2 (en) | 2013-07-17 | 2017-06-27 | Basf Se | High-reactivity polyisobutylene having a high content of vinylidene double bonds in the side chains |
US9341948B2 (en) | 2013-08-24 | 2016-05-17 | Polyera Corporation | Photopatternable materials and related electronic devices and methods |
CN106659895B (en) | 2014-07-11 | 2019-06-25 | 心脏起搏器股份公司 | Polymer feedthrough component for chronic implantable device |
CN104231207A (en) | 2014-09-18 | 2014-12-24 | 苏州市雄林新材料科技有限公司 | Recycled carbon fiber enhanced TPU (thermoplastic polyurethane) composite and preparation method thereof |
CN104592850B (en) | 2014-12-31 | 2017-06-23 | 三棵树涂料股份有限公司 | The preparation method of ultra-hydrophilic transparent antifogging coating |
CN104610902B (en) | 2015-02-12 | 2018-01-30 | 厦门誉匠复合材料有限公司 | Quick solidify afterwards polyurethane hot melt and preparation method thereof |
AU2016251650A1 (en) | 2015-04-23 | 2017-08-24 | Cardiac Pacemakers, Inc. | Compositions and methods for copolymer solutions with high weight percent copolymers |
US10405975B2 (en) | 2015-10-07 | 2019-09-10 | Boston Scientific Scimed, Inc. | Cultured cell leaflet material |
EP3390482B1 (en) | 2015-12-17 | 2021-03-03 | Cardiac Pacemakers, Inc. | Polyisobutylene-polyurethanes and medical devices containing the same |
US10472457B2 (en) | 2016-01-21 | 2019-11-12 | The University Of Akron | Initiators for living carbocationic polymerization |
JP6756844B2 (en) | 2016-05-10 | 2020-09-16 | カーディアック ペースメイカーズ, インコーポレイテッド | Thermosetting polyisobutylene-polyurethane and its manufacturing method |
CN106129383B (en) | 2016-09-05 | 2018-09-07 | 哈尔滨工业大学 | A kind of ball-shaped lithium-ion battery anode material and its synthetic method with two phase gradient distributed architecture of nanoscale |
EP3592786B1 (en) | 2017-03-07 | 2023-05-10 | Cardiac Pacemakers, Inc. | Hydroboration/oxidation of allyl-terminated polyisobutylene |
US10835638B2 (en) | 2017-08-17 | 2020-11-17 | Cardiac Pacemakers, Inc. | Photocrosslinked polymers for enhanced durability |
CN111479596B (en) | 2018-01-17 | 2023-04-07 | 心脏起搏器股份公司 | Blocked polyisobutylene polyurethanes |
JP7102017B2 (en) | 2020-10-27 | 2022-07-19 | 株式会社サンセイアールアンドディ | Pachinko machine |
-
2019
- 2019-01-15 CN CN201980006384.9A patent/CN111479596B/en active Active
- 2019-01-15 US US16/248,498 patent/US11472911B2/en active Active
- 2019-01-15 EP EP19720707.9A patent/EP3740253B1/en active Active
- 2019-01-15 WO PCT/US2019/013685 patent/WO2019143629A1/en unknown
-
2022
- 2022-09-23 US US17/951,682 patent/US11851522B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3740253B1 (en) | 2023-08-16 |
WO2019143629A1 (en) | 2019-07-25 |
EP3740253A1 (en) | 2020-11-25 |
US11851522B2 (en) | 2023-12-26 |
US20190218334A1 (en) | 2019-07-18 |
US11472911B2 (en) | 2022-10-18 |
CN111479596A (en) | 2020-07-31 |
CN111479596B (en) | 2023-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11851522B2 (en) | End-capped polyisobutylene polyurethane | |
EP3390482B1 (en) | Polyisobutylene-polyurethanes and medical devices containing the same | |
US11174336B2 (en) | Polyisobutylene-based polyurethanes | |
EP0461375B1 (en) | Crack-resistant polycarbonate urethane polymer prostheses | |
US5229431A (en) | Crack-resistant polycarbonate urethane polymer prostheses and the like | |
US9050388B2 (en) | In situ bonds | |
US8644952B2 (en) | Medical devices including polyisobutylene based polymers and derivatives thereof | |
Kang et al. | Polyisobutylene‐based polyurethanes with unprecedented properties and how they came about | |
AU2017263345B2 (en) | Thermoset polyisobutylene-polyurethanes and methods for making | |
US9309347B2 (en) | Bioresorbable thermoset polyester/urethane elastomers | |
WO1992004390A1 (en) | Biostable polyurethane products | |
CN116057101A (en) | Synthesis and use of high molecular weight and strength polyisobutylene-based polyurethanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: CARDIAC PACEMAKERS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DELANEY, JOSEPH T., JR.;RO, ANDREW J.;WULFMAN, DAVID R.;AND OTHERS;SIGNING DATES FROM 20200810 TO 20201106;REEL/FRAME:062197/0151 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |